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Abst 
PERFORMANCE EVALUATION OF MATERIAL DECOMPOSITION USING RAPID KVP-
SWITCHING DUAL-ENERGY CT FOR ASSESSING BONE MINERAL DENSITY  
 
John Matthew Spiridigliozzi Wait, B.S. 
 
Supervisory Professor: S. Cheenu Kappadath, Ph.D. 
 
Osteoporosis is diagnosed by assessing the bone mineral density (BMD) of the trabecular 
bone, and has previously been characterized with dual-energy x-ray absorptiometry (DXA) or 
single-energy computed tomography (SECT). Dual-energy computed tomography (DECT) is 
able to create two three-dimensional sets of images representing the densities of two materials 
in a given basis pair. DECT is theoretically capable of providing a true density measurement of 
trabecular bone material with the proper selection of material basis pair. 
Using the rapid kVp-switching GE HD750 scanner, the concentrations of various solutes 
were assessed in two-material syringe-phantoms in different experimental conditions with 
DECT material density images, SECT and DXA. RMS error was used to evaluate the accuracy 
of the DECT concentration measurements in air and regression was used to compare 
measurements made in other scanning conditions. The effect of anthropomorphic geometry 
was explored in concentric phantoms designed to model bone. The sensitivity of DECT, SECT, 
and DXA to changes in bone composition was compared. The correlation between different 
basis pair decompositions was evaluated. Finally, the correlation between DECT concentration 
measurements and DXA areal BMD (aBMD) measurements was assessed and used to 
develop a methodology to convert DECT concentration measurements to aBMD 
measurements.  
The RMS error of DECT concentration measurements made in air ranged from 9-244%. 
Measurements of concentration made off-isocenter or with different DECT techniques were 
 vi 
 
found to have a small (~5%) effect, but scattering conditions resulted in a reduction of 8-27% 
with similar trends observed in SECT data. In concentric phantoms, higher-attenuating material 
in the outer chamber increased measured values of the inner material for all measurement 
methods. DECT measurements had the highest sensitivity (2 mg/mL K2HPO4). Different DECT 
basis pairs were nearly perfectly correlated (R21). This was exploited to demonstrate a strong 
correlation (R2 = 0.988) between measured K2HPO4 concentration and DXA aBMD for different 
two-material phantoms. The relationship of DECT aBMD and DXA aBMD was highly correlated 
(R2 =0.983) but the limits of agreement (-0.16 to 0.57 g/cm2) were relatively large compared to 
clinical utility.  
This study suggests that corrections to output DECT concentration measurements may be 
necessary for clinically acceptable aBMD or trabecular BMD values. 
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1. Motivation 
Osteoporosis is defined clinically as a measured bone mineral density (BMD) that is more 
than 2.5 standard deviations below the mean value for a reference population of healthy “young 
adults” aged 30-40 of the same gender and race imaged at the same site (1–3). This reduction 
in BMD results in a lower yield strength than normal bone, which translates to an increased 
fracture risk for patients (4,5).  
Dual Energy X-Ray Absorptiometry (DXA) is the current gold standard for assessing BMD. 
The DXA scanner outputs an areal BMD (aBMD) with units of g/cm2 rather a true bone mineral 
density. Another modality that has been used for measuring BMD, although less frequently in 
the clinic, is single-energy computed tomography (SECT), which uses a single x-ray tube 
potential and measures tissue attenuation in Hounsfield units (HU). SECT may allow 
differentiation of trabecular bone from cortical bone, which is not possible with DXA. SECT 
used to make quantitative measurements of BMD using a reference phantom is referred to as 
single energy quantitative computed tomography (SEQCT). As a 3D technique, SEQCT may 
not be as susceptible as DXA to variations in measurement with bone size. However, SEQCT 
is susceptible to beam hardening artifacts, patient scatter, and the presence of fatty marrow 
which can be mistaken for reduced BMD (6–8). 
Dual energy quantitative computed tomography (DEQCT) uses two x-ray tube potentials 
and provides a three-dimensional dataset like SECT but the use of two effective beam energies 
could theoretically allow for correction of beam hardening artifacts seen in SEQCT (9). More 
importantly, DEQCT also has the ability to identify the composition of a given voxel instead of 
only the net attenuation, potentially allowing more accurate assessment of bone composition. 
DEQCT was first implemented in the late 70’s but in the past relied on two sequential single-
energy scans on a conventional CT scanner and costly image preprocessing techniques. 
Additionally, the propagation of errors in data collected at two different energies rather than one 
reduced the reproducibility of DECT relative to SEQCT. A commercial DECT scanner is now 
 2 
 
available that creates a dual-energy image with a single rotation utilizing a rapidly switching 
voltage across the cathode that results in a rapidly changing kVp (HD750, General Electric 
Medical Systems, Milwaukee, WI) and provides a ready-to-use software package capable of 
processing the dual-energy data (GSI Viewer, GEMS). This software offers the ability to 
decompose the signal from each voxel into the density of two user-defined materials assuming 
only those materials are present; for example, iodine and water. The two-material 
decomposition pairs are created by uploading a table of mass attenuation coefficients for the 
appropriate materials to the GSI Viewer software. Such a mapping has the potential to 
accurately assess BMD by modeling trabecular bone in terms of bone mineral (HA) and soft 
tissue, reducing the errors in SECT measurements. 
However, the performance of the material decomposition feature of the rapid-kVp-
switching DECT scanner has not been investigated extensively. There have to date not been 
any detailed studies investigating the performance of the DECT scanner using material 
decomposition to characterize bone composition. The objective of this study is to quantitatively 
investigate the sensitivity of GSI material decomposition images to known changes in the 
composition of several two-material samples in a variety of conditions and to evaluate its 
potential to assess BMD. 
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2. Introduction 
2.1 Osteoporosis and Bone Mineral Density 
  Human bones are comprised of two distinct compartments. The outer cortical 
compartment consists mostly of a dense tissue comprised of calcium hydroxyapatite (HA) and 
collagen, often referred to as “bone mineral” or “bone material.” The cortical bone forms a shell 
around the inner trabecular bone, also known cancellous bone. Trabecular bone consists 
primarily of bone mineral, red marrow, which produces blood cells, and yellow marrow, which is 
mostly fat. Bone mineral density (BMD) is the amount of bone material in a given volume of 
bone, typically per cubic centimeter. 
Osteoporosis is defined as “a disease characterized by low bone mass and 
microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a 
consequent increase in fracture risk (10).” Osteoporosis is defined clinically as a measured 
bone mineral density or bone mineral content that is more than 2.5 standard deviations below 
the mean value for a reference population of young adults of the same gender and race imaged 
at the same skeletal site (1,2). The standard deviation from the mean value is known as the T-
score.  A similar metric is the Z-score, for which the reference population is the patient’s own 
age group. The mean BMD for healthy women can vary by as much as 30% between reference 
populations (11). Bone mineral loss is known to increase with age, at greater rates in women 
than men (12–15). The normal incidence of osteoporosis increases with age, with 5% of 
women in western populations aged 50-54 estimated to have the disease, and up to 60.5% of 
women aged 85 or older (1). In postmenopausal women, osteoporosis is attributed to reduced 
estrogen levels. One action of estrogen is to partially block the resorption of bone stimulated by 
parathyroid hormone (16,17). In both women and men, bone loss may also result from a 
reduction of calcium absorption in the gut from dietary sources beginning in ages 55-60 and 65-
70 respectively and low rates of new bone formation (12,18).  Bone fractures and spinal 
compression are associated with osteoporosis, and it is therefore considered a disease (12). 
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While osteoporosis is a natural consequence of aging, there are several other known causes of 
reduced bone mineral (19,20). One of these is an increased risk of bone mineral loss 
secondary to some forms of cancer treatment (21–23). 
While there are many factors proposed to be associated with fracture risk (2,24,25), the 
reduced bone mineral density (BMD) associated with osteoporosis is thought to be most 
predictive (2). Bone mineral density is defined as the amount of bone mineral (HA) “per unit 
volume of  the organic bone matrix (3).” The BMD of osteoporotic bone is reduced primarily in 
the trabecular compartment (26,27) due to the larger surface area to volume ratio and 
metabolic activity (28,29). 
Trabecular bone in patients diagnosed with osteoporosis is known to have similar bone 
material composition and density to normal bone; it is the trabecular bone volume (TBV) that is 
reduced through loss of entire structural elements (4,14,27,30). This reduction in TBV results in 
a lower yield strength than normal bone in mechanical stress tests and severe changes are 
associated with compression fractures (1,4,5,30). The decrease in TBV coincides with an age-
related increase in fat in the marrow, although the effects are not necessarily related (8,13,31–
35).  
A number of different anatomical sites have been proposed and investigated for the 
assessment of trabecular BMD for fracture risk. Numerous studies have supported the 
recommendation that BMD is best assessed at the anatomical site which is thought to be at risk 
of fracture (15,36,37). Currently the lumbar spinal vertebrae are one of the most frequently 
monitored sites of BMD. This is in part because the lumbar spine is particularly prone to 
fracture; in osteoporosis these fractures are associated with an increased risk of hospitalization 
and mortality (38).  The lumbar spine is also preferred because of the large proportion of 
trabecular bone in the lumbar vertebrae relative to the rest of the skeleton. Correspondingly, 
the lumbar spine experiences a larger decrease in BMD in osteoporosis (15,39).  
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2.2. Measurement of Bone Mineral Density 
 Measurement of trabecular BMD demands a methodology that is accurate, repeatable, 
sensitive, and correlated with probability of fracture (2,40). Numerous methods for assessing 
BMD have been developed since 1964 (41). Three technologies of interest in this investigation 
are dual-energy x-ray absorptiometry (42), single-energy computed tomography (43,44), and 
dual-energy computed tomography (45).  
2.2.1. Dual Energy X-Ray Absorptiometry 
Dual Energy X-Ray Absorptiometry (DXA) is the current gold standard for assessing 
BMD. The modality gained rapid acceptance; a study by Intenzo et al. found that four times as 
many Medicare patients had a DXA examination performed in 2002 as in 1996 (2,195,548 vs 
510,105), an increase they attributed to “demographics, heightened public awareness of 
osteoporosis, and advances in therapy (46).” DXA is favored because it is non-invasive and 
precise, with a reported 0.5-2% coefficient of variation (CV) for posteroanterior (PA) lumbar 
spine measurements (47). The DXA scanner creates a radiograph with two x-ray beams 
generated from bremsstrahlung radiation at two different peak tube potentials (kVps). In the 
DXA implementation by Hologic (Hologic, Bedford, Massachusetts), the x-ray source switches 
between high and low kVp resulting in polychromatic beams with high and low effective 
energies (48) that are attenuated by soft tissue and bone according to the Beer-Lambert law 
and the energy-dependent mass attenuation coefficient ((/). In principle, the two different 
effective energies allow the determination of the areal density * of one material (bone, +) 
without contribution of the other (soft tissue, ,) from the integrated high and low-effective 
energy x-ray beam transmissions -. and -/, as illustrated in the DPA equation (49) (Equation 
2.2.1-5) derived below: 
-/  -/,123456,786945:,78:; Equation 2.2.1-1 
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-.  -.,123456,<86945:,<8:;. Equation 2.2.1-2 
By taking the logarithm of both sides and setting =  ' ln-/-1, Equation 2.2.1-1 and 2.2.1-2 
may be re-written as 
=/  >?@,/ *@  >?A,/ *A  Equation 2.2.1-3 
=.  >?@,. *@  >?A,. *A. Equation 2.2.1-4 
Equation 2.2.1-3 or Equation 2.2.1-4 can be written in terms of *@ and substituted into the 
other and solved for *A: 
*A  B73456,7/456,<;B<45:,73456,7/456,<;45:,<. Equation 2.2.1-5 
In equation 2.2.1-5, the terms >?A,/ and 
>?A,. are known from the effective energy of each beam 
and the composition of bone mineral (hydroxyapatite) (50). The ratio >?@,/ / >?@,.is calculated as 
=//=.  either for each scan line or averaged over all regions containing only soft tissue (50,51), 
since the composition of the soft tissue is not known. At MD Anderson, most DXA examinations 
include an anteroposterior (AP) measurement of the lumbar spine. The typical screening 
examination is vertebrae L1-L4 and each femoral neck. 
The widespread use of DXA has resulted in a large body of normative data from which 
an individual diagnosis of osteoporosis can be made (11,52–58). Despite its ubiquitous use, 
however, DXA has an important drawback. The scanner outputs a bone mineral “density” with 
units of g/cm2, which is not a true bone mineral density but in fact an estimate of bone mineral 
content within a given areal projection. This is often referred to as an areal bone mineral 
density, or aBMD. Because it is not a true volumetric density, an aBMD measurement is 
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necessarily an inaccurate measurement of true BMD. Additionally, although the quantity of 
interest is BMD of the trabecular portion of the bone, due to the two-dimensional nature of DXA 
imaging cortical bone mineral is incorporated into the aBMD as well. As a result, the sensitivity 
of DXA is theoretically reduced, which impacts its effectiveness as a screening modality (58). 
2.2.2. Single-Energy Computed Tomography 
 Single energy computed tomography (SECT) is an alternative noninvasive method for 
quantitative bone analysis (40). Like DXA, SECT images are produced by integral 
measurements of x-ray attenuation in tissue. A computed tomography (CT) scanner creates a 
three-dimensional image dataset from the rotation of an x-ray tube and detector (x, y axes) and 
patient translation (z axis), most often using a filtered back-projection reconstruction in which 
each beam profile is deconvolved with a sharpening kernel and then superimposed in image 
space over 360 degrees (59,60). The resulting images are attenuation maps defined by the 
characteristic linear attenuation coefficient (µ) of the tissues in the field of view (FOV). Each 
volume element or “voxel” of the image is associated with a Hounsfield unit (HU) (also called 
CT number) that is defined as 
CDE, &,  ,   1000 ! >F,G,H,I>FJ>FJ   Equation 2.2.2-1 
where (EK is the linear attenuation coefficient of water. Because µ is a function of energy (E), 
SECT acquisitions with different kVps will yield different HU for the same tissue. 
While trabecular BMD is sometimes assessed in terms of the average HU in a region of 
interest (ROI) (61,62), typically for BMD assessment the CT device is calibrated with a known 
standard to output units of true density (usually mg/cm3 or mg/mL). This approach is commonly 
referred to as quantitative computed tomography (QCT). 
Single-energy QCT (SEQCT) for the assessment of bone composition has been in use 
since 1976 (43,44). Historically, SECT measurements were calibrated with known 
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concentrations of dipotassium phosphate (K2HPO4) in water (26,27,63–65). Dipotassium 
phosphate is a useful substitute for bone material due to its similar effective atomic number, 
physical density, and linear attenuation coefficient (F for effective energies in the range of CT, 
as well as its solubility in water (63,66). Solid phantoms of varying concentrations of HA in 
water-equivalent plastic have also been used (65,67). In QCT studies investigating the 
influence of fat in the marrow space on measurements, ethanol has often been used as a fat 
substitute (33,66,68,69) due to its similar mass attenuation coefficient and its solubility in water. 
Water-soluble materials allow for completely uniform phantom composition assuming they do 
not precipitate out of the solution. 
SEQCT outputs a true volumetric bone mineral density (vBMD), a potentially major 
advantage over DXA. The three-dimensional nature of SECT data also allows for differentiation 
between the trabecular and cortical compartments of bone. The potential for bone densitometry 
measurements with CT was realized not long after the introduction of the device (43,44,70). 
Within its first decade, SECT became established as a useful alternative to single and dual-
photon absorptiometry, planar imaging predecessors of DXA that used radioisotopes rather 
than x-rays, for the assessment of bone mineral density (71). SEQCT bone mineral 
assessment available in the mid-90’s had precision errors (CVs) of 2-4% (40); modern-day 
SEQCT with multislice helical scanners has improved this to a 1.4% “best case” precision error 
and a 3.6% “worst case” error, with a routine measurement estimated to have a precision error 
of 1.8% (72). SEQCT is generally more sensitive to changes in bone mass than projection 
technologies (40,73). In a cross-sectional study of 108 postmenopausal women conducted by 
Gulgielmi et al., SEQCT estimated a rate of bone loss in the lumbar spine over four times 
greater than the rate estimated by PA DXA (1.96% vs 0.45%) (74). The same study also found 
that SEQCT was a significant predictor of osteoporosis in the lumbar spine, but PA DXA was 
not. In general, SEQCT BMD has been found to be at least as predictive of fracture risk as AP 
DXA aBMD in the lumbar spine for postmenopausal women (25). 
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Despite the demonstrated utility of SEQCT, there are a number of disadvantages that 
prevent it from being the preferred screening method for generalized fracture risk. Although 
QCT may be implemented on existing SECT scanners, a DXA scanner is less expensive to 
acquire and operate and has no other demands placed on it other than the assessment of 
BMD. In addition, a SEQCT spine examination delivers 1.2-120! more radiation dose to the 
patient than a DXA spine examination (0.016-1.5 mSv depending on type of examination for 
SEQCT vs. 0.013 mSv for DXA) (75). SEQCT is also a less precise modality than DXA due to 
the more numerous scan parameters, in which variations contribute to the total error (72,76). 
While the true density measurements of vBMD are more accurate characterizations of 
bone tissue than DXA aBMD, SEQCT suffers from other sources of inaccuracy. A well-studied 
limitation on SEQCT measurements is beam hardening (6,77,78), a phenomenon that results 
from the polyenergetic x-ray spectrum used to produce the images (the effect is present in DXA 
as well (79)). As the polyenergetic beam travels through a patient, lower-energy x-ray 
components of the beam are attenuated. The result is a net shift upward in the effective energy 
of the beam (“hardening”), resulting in lower attenuation measurements than expected. 
Because of these lower HU measurements, beam hardening artifacts affect SEQCT primarily 
by reducing the observed vBMD (64,80). Beam hardening can be addressed and corrected in a 
number of ways in SEQCT, including empirical modeling (80), calculations based on assumed 
materials present in the image (81), and reference phantoms (6). However, none of these 
methods are completely capable of removing beam hardening artifacts in an individual 
examination. 
SEQCT measurements are also confounded by the effects of x-ray scatter. In the range 
of effective energies used in CT examinations, “scatter” refers primarily to Compton scatter, 
which has the dominant interaction cross section or probability of interaction in water 
(compared to the photoelectric effect, which has the next largest cross section). Compton 
scatter is an inelastic process in which an x-ray photon collides with a free charged particle (in 
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a patient, usually an electron) and a scattered x-ray photon with reduced energy leaves the 
collision site at an angle to the original path. In CT imaging, this scattered x-ray photon is 
detected by the imaging equipment but the signal does not correspond to the original 
(“primary”) beam path, so it appears as noise and degrades the contrast of the resultant image 
along with other background noise sources.  
Another consequence of scatter was illustrated by Glover (82). The total intensity -L of 
radiation at the detector can be represented as a sum of the contributions of the intensity of the 
primary beam -M and of the total scattered radiation -N: 
-L  -O  -@. Equation 2.2.2.-2 
The detected x-ray attenuation is logarithmically transformed during the reconstruction process, 
so equivalently 
log-L  log -O Q1  R6RST. Equation 2.2.2-3 
If the scatter to primary ratio -@/-M is much smaller than 1, eq. 2.2.2-3 may be re-written: 
UL  UO ' R6RS  UO  U@  Equation 2.2.2-4 
where UL V ' log -L, UO V ' log -O and U@ V -@/-O. The result is the measured total logarithmic 
attenuation UL is reduced from the expected measurement by an amount equivalent to the 
scatter to primary ratio. When the x-ray beam passes through a highly attenuating region, there 
is a much greater decrease in -O than -@ so a noticeable decrease in HU from the expected 
value will be observed. An example is when a flat x-ray beam with no primary attenuator 
encounters a homogenous water-filled cylindrical phantom meant to represent a patient. The 
beam is unevenly attenuated by the patient and so a “cupping” artifact is observed, in which the 
HU measured in the center of the phantom is less than HU measured around the edges. This 
effect is compensated for in CT scanners with the use of a bowtie filter, an attenuating object 
shaped in such a way to ensure the beam is roughly uniformly attenuated along its entire 
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profile. Different-sized patients necessitate different-sized bowtie filters. This selection is never 
exact and as a result patient size is known to affect SEQCT measurements (7,83,84). 
The accuracy of SEQCT is perhaps most dramatically affected by the amount of fat in 
trabecular bone. Because SEQCT is calibrated with varying compositions of bone mineral 
equivalent material in water and because fat is less attenuating than water (typically -50 to -100 
HU compared to 0 HU for water), the presence of fat in the marrow space causes a systematic 
error in SEQCT measurements.  Because marrow makes up approximately 75-80% of 
trabecular bone, and fat approximately 25-75% of marrow, the systematic error can be large 
(85). In addition, the presence of unknown quantities of fat causes an underestimation of vBMD 
of 10-30% at 80 kVp and 20-40% for tube potentials up to 130 kVp (8). An adjustment of 
SEQCT measurement can be made based on normative data on fat content over age and the 
underestimation of vBMD over fat content (86). However, individual variation in vertebral fat still 
accounts for 12-24% of the residual inaccuracy at 80 kVp and 30-40% up to 130 kVp. 
2.2.3. Dual Energy Computed Tomography 
 Dual-energy computed tomography (DECT) has the potential to overcome the 
limitations on accuracy of SECT. Dual-energy computed tomography, first proposed 
simultaneously with SECT (70), utilizes the same imaging methodology as single-energy 
computed tomography, but with acquisitions at two effective x-ray energies instead of one. 
When attenuation data have been acquired at two different effective energies, either a 
preprocessing (projection based) technique (9) may be applied to the raw data or a 
postprocessing (image based) technique (87) may be applied to the resulting image sets to 
create new images that are able to distinguish between two different materials in a given voxel 
rather than providing a net attenuation measurement. A preprocessing technique is 
advantageous because it is in theory free of beam hardening artifacts due to the decomposition 
functions used (88,89). However, preprocessing is technically challenging and requires access 
to the raw data; until recently the technique was limited to a few research centers (90,91). 
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 The most studied preprocessing technique is based on the work of Alvarez and 
Macovski (9). The method relies on the principle that the linear attenuation coefficient (E of a 
given material varies with the effective energy of an x-ray beam according to a linear 
combination of the photoelectric effect and Compton scattering. The cross section of the 
photoelectric effect is inversely proportional to the third power of effective energy (E", 
whereas the cross section of Compton scattering is described by the Klein-Nishina formula 
WXYE, as described in the paper. The linear attenuation coefficient in a given (multislice) CT 
image, through empirical testing, is approximated by the function 
(&,  , E  Z&,  ,  F[  Z$&,  WXYE. Equation 2.2.3-1 
The coefficients Z and Z$ depend on the atomic number \, mass density ), and atomic weight 
] of the material, such that 
^Z  _ ?` \aZ$  _$ ?` \ b   , Equation 2.2.3-2 
where _ and _$ are empirical constants, c  4, and all parameters except for c are dependent 
on the location in the image (x, y). An individual photon in the x-ray beam of the CT scanner 
measures the line integral of (&,  , , E, that is, 
d (&,  , , E ef  ] F[  ]$WXYE  Equation 2.2.3-3 
where 
]  d Z&,  ,  ef and ]$  d Z$&,  ,  ef . Equation 2.2.3-4 
If two measurements were made with x-rays beams of two different energy spectra , and ,$, 
then the two different intensity measurements -  can be obtained: 
g-], ]$  h d ,E2`i F[j `klmnFeE-$], ]$  h d ,$E2`i F[j `klmnFeEb Equation 2.2.3-5 
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where h is the total measurement time and - is the total energy. Through these two intensity 
measurements, the coefficients ] may be derived. If two materials (a basis pair) are assumed 
to be in a given voxel or conversely if a constant density is assumed, the density (and for most 
materials, the electron density) or material properties (atomic number, mass) can be obtained. 
The former method can be used to produce two material decomposition image sets, where the 
voxels in each set represent the density of one material assuming the other is present.  
Separation of the spectra is important for dual-energy reconstruction; the lower-energy beam 
should be attenuated a relatively large amount by the more material sensitive photoelectric 
interactions, while the higher-energy beam should be dominated by Compton scattering; in 
principle greater separation between the two images gives greater material discrimination. 
However, the more the lower energy beam becomes attenuated, the more the signal to noise 
ratio decreases (92). 
It is important to note that the equations in (13) are non-linear and cannot be solved 
exactly. The choice of reconstruction function will impact the accuracy of any preprocessed 
DECT measurement. It is also important to note that the Alvarez and Macovski method does 
not address the problem of scattered radiation (9). It is also important to note that unlike in DXA 
dual-energy reconstructions, the two materials used in DECT material decomposition image 
sets are input by the user and assumed to be known. Density for each basis pair material is 
derived solely from first principles. DXA, by contrast, only assumes one material is known (HA) 
and applies an empirical correction to the areal density based on indirect measurements of the 
second material (soft tissue). In this way, DXA essentially normalizes the density measurement 
for each individual patient whereas no normalization is applied in DECT acquisitions. While 
DXA aBMD is assessed daily with a quality control (QC) phantom provided by the 
manufacturer, there is currently no similar calibrated standard for assessing DECT density 
measurements. 
In principle, there are a number of ways to implement DECT acquisition. The simplest 
method to obtain two spectra is to simply repeat a SECT scan twice at different kVps (93,94). 
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However, due to the sequential nature of the scans, this method is prone to image artifacts 
caused by patient motion in a clinical situation. An implementation involving a single scan is 
preferred. In one proposed implementation, a split filter of differing thickness is placed over the 
tube window such that the beam on one side of the filter passes through more attenuating 
material and is harder than the beam on the other side (95). In another, the detector is split 
such that the two sides are more sensitive to higher and lower-energy photons (96). Besides 
poorer discrimination between Compton scattering and the photoelectric effect, these 
(research) methods also prevent single-energy acquisitions on the same scanner. One solution 
is an implementation in which two sources set to two different kVps are set at 90° from one 
another and rotated around the patient simultaneously paired with two detectors (97). The 
current most commonly used implementation method has the disadvantage of reducing the 
effective FOV of the scanner when used for DECT due to the small size of one of the detectors 
used (98) and also relies on postprocessing imaging techniques that do not compensate for 
beam hardening (89).  Another implementation involves a single source that rapidly switches 
between two kVps paired with a single detector (99,100). 
One of the first applications of DECT was quantitative assessment of bone mineral 
(DEQCT) (45) by Genant et al. using sequential scanning and postprocessing. A follow-up 
study conducted a much more in-depth characterization of the technique (68). Genant and 
Boyd measured the CT number and fraction K2HPO4 of varying solutions of K2HPO4 in water 
and K2HPO4 –water–ethanol in single-chamber cylinders to simulate cortical and trabecular 
bone and in concentric cylinders to simulate bone geometry. The two chambers (trabecular and 
cortical) of the concentric phantom were measured separately and as an integral. The 
investigators found excellent correlation of CT number with K2HPO4 in both the solid and 
concentric cylinders and lower than expected CT numbers in the middle of cylinders with thick 
cortical bone, indicating beam hardening error. In measurements of the K2HPO4 concentration, 
DEQCT was found to have greater accuracy, far less susceptible to ethanol concentration, but 
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less precision. The investigators concluded that DEQCT might be more useful for diagnosis 
and SEQCT for follow-up. 
Many subsequent studies confirmed these results (76,85,94,101). In the late ‘80s, 
DEQCT studies were reporting a standard error of the estimate of 3-6% in normal women and 
6-10% in older women, compared to 6-9% and 10-15% respectively with SEQCT, but a three to 
fourfold reduction in precision and a doubling of dose (73,102). Research in DEQCT for vBMD 
measurement mostly ceased by 1996, when Genant et al. published a literature review on 
noninvasive bone analysis that briefly concluded the poorer precision and higher dose of the 
technique made it suitable only for research applications (40). 
Recently, interest in DECT has re-emerged with the advent of the first commercial 
DECT scanner in 2006 (97). A variety of studies have been published on the potential clinical 
application of these scanners (103–105). However, we are not aware of any studies to date 
assessing the capability of these new DECT scanners for characterizing BMD. A commercial 
DECT scanner with rapid kVp switching (rsDECT) and dual-energy preprocessing modeled 
after the methods of Alvarez and Macovski is now available (100). The GE HD750 (General 
Electric Medical Systems, Milwaukee, WI) includes pre-packaged image analysis software 
called GSI Viewer (General Electric Medical Systems, Milwaukee, WI) that allows for two-
material decomposition image sets to be created based on user-defined material basis pairs. 
The purpose of this present study is to characterize this feature of the scanner and its potential 
for vBMD measurement. 
  
 16 
 
2.4. Hypothesis and Specific Aims 
Hypothesis: Rapid-kVp-switching dual energy computed tomography (DECT) is capable of 
producing material density images with an accuracy better than 95% which are more sensitive 
to changes in bone-equivalent material than dual-energy absorptiometry (DXA) and can be 
related to DXA areal bone mineral density (aBMD) measurements to distinguish osteoporotic 
from normal bone within a 95% confidence interval.  
Specific Aim I: To quantitatively investigate the performance of material density 
concentrations, SECT, and DXA to known changes in the composition of several two-
material samples. 
• Subaim 1: To determine the accuracy of DECT material decomposition when 
characterizing two-material samples using the constituent material 
decomposition basis pairs and to compare the performance and sources of 
variability of DECT material density images, SECT, and DXA for a variety of 
imaging conditions. 
• Subaim 2: To compare the performance of DECT material density images, 
SECT, and DXA in a concentric phantom designed to simulate the geometry of 
bone. 
• Subaim 3: To evaluate the relative sensitivity of DECT material density images, 
SECT, and DXA to changes in K2HPO4 concentration. 
• Subaim 4: To quantitatively investigate the correlations between several 
constituent and non-constituent DECT basis pairs for given two-material 
samples. 
Specific Aim II: To quantitatively investigate the relationship between DECT material 
density concentrations and DXA measurements and compare a DECT and SECT-
derived aBMD with DXA. 
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• Subaim 1: To analyze the correlation of DECT concentration measurements 
using the K2HPO4-water basis pair with DXA aBMD measurements. 
• Subaim 2: To develop a methodology to calculate DECT and SECT-based areal 
bone mineral density in g/cm2
 
of HA and investigate the correlation of each to 
DXA-based aBMD. 
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3. Specific Aim I: Performance of DECT and Measurement Method Comparison 
3.1. Subaim 1: Accuracy of DECT and Comparison of Measurements 
3.1.1. Material Decomposition Accuracy 
3.1.1.1. Materials and Methods 
A characterization of the accuracy of material density image-derived concentration 
measurements was sought. Syringe-phantoms were designed to assess the accuracy of the 
material density images in the simplest case of decomposing two-material samples into their 
constituent basis pairs. Seven 30 mL solutions of iodinated contrast (Optiray 320, Mallinckrodt 
Pharmaceuticals, St. Louis, MO) and water, ethanol and water, dipotassium phosphate 
(K2HPO4) and water, and a 10 gm% K2HPO4 and water solution plus denatured ethanol were 
prepared in 60 mL syringes with a diameter of 2.5 cm. The materials were selected due to their 
ubiquitous use as CT contrast (Optiray 320), and as bone (K2HPO4) and fat (ethanol) 
surrogates in CT research. The syringe-phantoms containing both 10 gm% K2HPO4 solution 
and ethanol were constructed (106) to model the composition of trabecular bone, containing 
both fatty yellow marrow and bone material. 
The concentration of each solute (Optiray 320, ethanol, and K2HPO4) varied in 5% by 
volume increments from 0-30%, for a total of 21 solutions. For the additional seven 10 gm% 
K2HPO4 solution-ethanol syringe-phantoms, the ethanol concentration was varied in 5% by 
volume increments from 0-30% representing progressively more yellow marrow. However, for 
the remainder of this paper the 10 gm% K2HPO4 solution is considered the “solute” since, 
representing bone material, it is the material of interest. These concentrations were selected to 
give a broad range of material densities for each solute, particularly for the K2HPO4, which 
nears its precipitation point at 30% concentration. 
In preparing solutions containing K2HPO4, the K2HPO4 powder was weighed on a gram 
scale with an approximate uncertainty of ±0.001 g provided by the manufacturer. Distilled water 
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and ethanol were measured out in 5 and 1 mL volumetric pipettes with an estimated 
uncertainty of 0.01 mL each. K2HPO4 is known to create an excess volume when dissolved in 
water (107) so the concentration was adjusted based on volumes measured with the syringes. 
The uncertainty in volume from syringe measurements (± 0.05 mL) was translated to error bars 
in subsequent analysis (Section 3.1.1.2.1). The excess volume effect is also known for ethanol 
added to water, and the concentration was adjusted according to fourth-order polynomial fit to 
partial volume tables found in Benson and Kiyohara (108). This effect is notably much smaller 
than for K2HPO4. Excess volume data was not available for Optiray 320-water and K2HPO4-
water-ethanol solutions, but visual assessment of the syringe-phantoms determined that 
volume corrections were not necessary.  
Scans were acquired with the GE HD750 dual-energy CT scanner using the GSI-6 dual-
energy protocol (medium body filter, rotation time 1s, beam width 40 mm, CTDIvol 33.43 mGy). 
Each syringe-phantom was placed in the central bore of an electron density phantom (Model 
62, CIRS, Norfolk, VA), which measures 13 x 2 x 10.6 in.  (33 x 5.1 x 27 cm), with the portion 
containing the solution protruding in air and the central bore aligned at isocenter (Figures 1-2). 
Eight 5 mm images were acquired and reconstructed using the GE GSI viewer software into 
material density maps using the constituent basis pair (for example, Optiray 320 and water). 
The mass attenuation coefficients for each material in the basis pair loaded to the GSI software 
were taken from the NIST database using XCOM (109), except for water, which was available 
as a pre-determined material. Optiray 320 was programmed as a mixture according to the 
composition listed in the package insert. For each syringe-phantom, the mean solute 
concentration and standard deviation was recorded from a circular region of interest (ROI) of 
250-259 mm2 drawn in the center of the transaxial area of the syringe (Figure 3) in the central 
image (image 4 or 5).  
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Figure 1: CIRS 62 electron density phantom, pictured with included tissue-equivalent inserts 
placed in bores. The inner “head” portion can be removed or it can remain in place to simulate 
a “body” measurement.  
 
Figure 2: Configuration of materials used for in-air DECT and SECT measurements. Each 
syringe-phantom was inserted in the central bore of the electron density body phantom with the 
solution protruding in air. Eight images that span the solution volume were acquired, and a 
measurement was made on the central image (image 4 or 5) as shown. 
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Figure 3: Illustration of procedure for making material density measurements in GSI Viewer. 
The image shown is a material density map; a circular ROI is drawn in the cross-section of the 
syringe-phantom. 
 
For comparison, immediately following the DECT scans, axial SECT images were 
acquired sequentially at 120 kVp/150 mA and 80 kVp/200 mA with 1s tube rotation time and 
the medium body filter selected. The corresponding mean and standard deviation of the CT 
number were measured in the GSI Viewer software and recorded for all image sets using the 
same ROI size range and approximate position as the concentration measurements. The 
syringe-phantoms were also scanned individually with a DXA scanner (Discovery, Hologic, 
Bedford, MA) with each syringe-phantoms placed horizontally between five 3/8 in. (9.5 mm) 
thick PMMA slabs on top and three slabs beneath to simulate patient scattering conditions in a 
lumbar spine measurement (Figure 4). aBMD measurements were made using vendor supplied 
software in lumbar spine analysis/subregion array spine mode by manually drawing a 
rectangular ROI over the central axis of the syringe-phantom to segment the “bone” region 
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(Figure 5). The Hologic Discovery scanner produces x-ray beams with switching tube potentials 
of 100 and 140 kVp. 
 
Figure 4: Positioning of syringe-phantom for DXA measurement. Five 3/8 in. (9.5 mm) PMMA 
slabs are placed above and three below to simulate patient scattering conditions in a lumbar 
spine measurement. 
 
Figure 5: DXA measurement of a two-material syringe-phantom with the vendor-provided 
software. A "bone map" was manually drawn on the central axis. The BMD was reported in 
areal density (g/cm2). 
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The material density image-derived solute concentrations were compared with the 
known concentrations and the data was fit with a linear regression.  The Pearson’s correlation 
coefficient (r) was computed. The probability of a slope of unity and the probability of a y-
intercept equal to 0 were determined with an f-test using GraphPad Prism 6 statistical analysis 
software (GraphPad Software, La Jolla, CA).  Regressions with a y-intercept consistent with 0 
within the 95% confidence intervals were re-plotted with the y-intercept set to 0. The accuracy 
was evaluated by calculating the total root mean square (RMS) error and the RMS error as a 
coefficient of variation (CV) of the solute across all concentrations for the relevant syringe-
phantoms. The material density image-derived solute concentrations and the known 
concentrations were also compared using Bland-Altman analysis (110). 
An evaluation of the different sources of variation in the DECT scanner measurements 
was necessary in order to determine the accuracy of the concentration measurements from the 
material density images.  Four sources of variation were identified: variation in phantom 
preparation (M), variation between images in each acquisition (o), variation between 
acquisitions (p) and random variation in concentrations across the ROI or noise (a). 
In order to estimate variation in phantom preparation, M, four 25% Optiray 320 syringe-
phantoms and three 2.5% K2HPO4 syringe-phantoms were independently prepared. These 
concentrations were selected to represent estimated “worst-case” variation for the two 
respective materials based on the phantom preparation method. These syringe-phantoms were 
scanned with DECT using the same methodology as described for the other syringe-phantoms. 
The phantom preparation variation M was not evaluated for ethanol and 10gm% K2HPO4 
solution syringe-phantoms because due to the large inaccuracies observed relative to the other 
syringe-phantoms, it was judged not worth the time and financial resources to obtain the 
relevant data. In order to estimate variation between images, o, the standard deviation of the 
mean was determined from DECT data in the same location on an eight-image stack of three 
concentrations (10, 20, 30%) of each solute or ethanol. The two outermost images (Images 1 
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and 8) for each stack were found to have partial volume artifacts with air and the electron 
density phantom respectively and were not included in the analysis. To estimate variation 
between scans, p, a single 25% Optiray 320, a single 2.5% K2HPO4 syringe-phantom, and the 
25%-ethanol 10 gm% K2HPO4 solution syringe-phantom were scanned three times on three 
separate dates using the methodology described earlier in this section, and the standard 
deviation of the mean concentration was determined. The p was not evaluated for ethanol.  
Finally, the noise (a) of each measurement of all Optiray 320, ethanol, K2HPO4, and 10 gm% 
K2HPO4 solution concentrations was defined as the standard deviation of the mean. The total 
standard deviation L of each mean concentration was then calculated from combining these 
four standard deviations in quadrature. The phantom preparation variation M was not included 
in the total variation for any syringe-phantom containing only water. 
For comparison, the same method was used to calculate each variation for SECT and 
DXA measurements, using the same syringe-phantoms to calculate M. The differing nature of 
DXA aBMD measurements required only M and p to be evaluated. DXA produces a single 
image rather than an image stack and the standard deviation or variability or “variation” of the 
measurement displayed is not provided by the DXA software. 
3.1.1.2. Results 
3.1.1.2.1. DECT Accuracy 
The magnitude of each source of variation for each two-material syringe-phantom 
imaged with DECT is summarized for a representative concentration in Table 1.Measurements 
of the ethanol syringe-phantoms in general had the highest variation. 
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Table 1: Calculated sources of variation of a solute concentration measurement in air by DECT 
for a 25% concentration. The mean value and CV of the total variation are also shown for 
reference. The total variation is the sum of the individual variabilities added in quadrature.  
DECT Variation (Air) 
Optiray 
25% 
(mg/mL) 
Ethanol 25% 
(mg/mL) 
K2HPO4 25% 
(mg/mL) 
10 gm% K2HPO4 
Solution 25% 
(mg/mL) 
Phantom Preparation (σp) 3 - 10 - 
Image to Image (σi) 2 29 5 10 
Scan to Scan (σr) 1 - 5 10 
ROI Noise (σn) 4 41 3 10 
Combined (σt) 5 50 13 17 
Mean Value 349 451 558 912 
CV (Unitless) 2% 11% 2% 2% 
 
The data associated with the calculation of variation between images, o, is summarized 
in Figure 6. The measured mean concentration across the central six images in the image 
stack associated with each syringe-phantom is plotted with the associated distance from the 
center of the image stack (taken as image 4).  Each measurement was acquired with the ROI 
placed in the same location in each individual image stack. Overall, except for ethanol-water, 
the variation across the image stack was small (0.6-1%).  
The ROI noise, a, was found to vary with concentration (Figure 7). A clear increase in 
noise is seen in measurements made in syringe-phantoms containing Optiray 320 and K2HPO4, 
but no clear trend is visible in the other two sets of syringe-phantoms. The dominant source of 
variation differed between each set of syringe-phantoms.  
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Figure 6: Mean concentration (mg/mL) measured in an ROI placed in the same position over 
each of the middle six images of the image stack acquired for three Optiray 320, ethanol, 
K2HPO4, and 10 gm% K2HPO4 solution syringe-phantoms. The CV for Optiray was 0.6%, the 
CV for ethanol was 6%, the CV for K2HPO4 was 0.9%, and the CV for 10 gm% K2HPO4 solution 
was 1%. 
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Figure 7: The standard deviation of material density image solute concentration measurements 
of each syringe-phantom as a function of the measured mean solute concentration. 
 
The material density image-derived solute concentrations of each constituent basis pair 
are plotted against the known concentration of each material in Figure 8. The data were 
positively correlated, and the squared Pearson’s correlation coefficients of each regression 
were >0.986 (p < 0.0001) (Table 2).  The significance tests (f-tests) and RMS errors are 
summarized in Table 3. The f-test found the fitted slope was significantly (p < 0.05) different 
from 1 for all solutes and the intercept was significantly different from zero only for ethanol. The 
RMS errors for Optiray 320, K2HPO4, 10 gm% K2HPO4 solution, and ethanol, were 9%, 10%, 
12%, and 244% respectively. The especially large RMS error in ethanol stems from the large 
offset (~252 mg/mL) seen with ethanol-water basis pair measurements. While concentration 
measurements were significantly linearly correlated with the known concentration, the average 
RMS error was greater than 5% for all materials.  
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Table 2: Pearson’s correlation coefficients (squared) for correlation, y-intercept, and slope of 
concentration measurements on images acquired using DECT in air with the GSI-6 protocol 
and the concentration of each solute or ethanol. Regressions with a y-intercept consistent with 
0 within the 95% confidence intervals were re-plotted with the y-intercept set to 0. 
Solute R2 Slope 
y-intercept 
(mg/mL) 
Slope (intercept = 0) 
Optiray 320 0.995 1.08 ± 0.08 -8 ± 20 1.06 ± 0.04 
Ethanol 0.997 1.30 ± 0.09 252 ± 13 
 
K2HPO4 0.999 1.08 ± 0.04 0 ± 14 1.08 ± 0.02 
10 gm% K2HPO4 
Solution 
0.993 1.0 ± 0.1 83 ± 90 1.12 ± 0.01 
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Figure 8: The material density image-derived concentration value of each solute is compared to 
the known concentration. A linear regression was applied for each solute. The line of 
equivalence is shown for reference. Error bars on the y-axis indicate total variation for each 
measurement and are too small to be visible on all but ethanol
 
measurements. Error bars on 
the x-axis for K2HPO4, represent uncertainty in known concentration based on the observed 
volume but are too small to be visible in this plot. 
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Table 3: Statistics for material density image accuracy evaluation. The probability that each 
linear regression of the measured solute concentration vs. the known concentration has a slope 
of 1 and intercept of 0 is recorded, as well as the RMS error as an absolute and percentage of 
the average concentration for all syringe-phantoms of each solute. Significance in this 
experiment was defined as p < 0.05. 
Solute 
P value 
(Significant 
correlation) 
P value 
(Slope = 1) 
P value (0 
Intercept) 
RMS Error 
(mg/mL) 
RMS 
%Error 
Optiray 320 <0.0001 0.0157 0.3482 18 9% 
Ethanol <0.0001 0.0003 <0.0001 289 244% 
K2HPO4 <0.0001 <0.0001 0.9582 31 10% 
10 gm% 
K2HPO4 
Solution 
<0.0001 <0.0001 0.065 109 12% 
 
Bland-Altman analysis (110) is a statistical method for comparing the agreement 
between two measurement techniques. The mean difference between two measurements 
(bias) is evaluated and the “limits of agreement,” or the mean ± 2! the standard deviation, are 
considered to be a range within which most differences would fall; variations within the limits of 
agreement must be clinically acceptable. The limits of agreement are calculated for a specific 
sample of the population of all measurements, so a 95% confidence interval may be calculated 
for these limits for entire the population by considering the degrees of freedom of the sample, 
the proper q value to give 95% confidence and the standard error f such that the interval is the 
bias ± fq. 
To further investigate the accuracy of the material density image-derived concentration, 
we performed Bland-Altman analysis by comparing measured and expected concentrations for 
all syringe-phantoms, summarized in Figure 9 and Table 4. In particular, the 95% limits of the 
bias corresponding to K2HPO4 (9-43 mg/mL) are large relative to the mean change in K2HPO4 
concentration equivalent that signifies osteoporosis in postmenopausal women in QCT (about 
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48 mg/mL) (111). The 95% confidence interval and limits of agreement are consistent with a 
bias of 0 mg/mL only for Optiray 320.  With this analysis both sets of syringe-phantoms 
containing ethanol yielded especially large differences in measured concentrations from 
expected. 
 
Figure 9: Bland-Altman analysis of material density image concentration measurements 
compared with known concentration. Error bars on the y-axis represent the total variation of the 
concentration measurements. 
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Table 4: Bland-Altman analysis of material density image-derived concentration measurements 
compared to the known concentration. 
Solute 
Average 
Difference 
(Derived-
Known) 
(mg/mL) 
Lower Limit of 
Agreement of 
Difference 
(mg/mL) 
Upper Limit of 
Agreement of 
Difference 
(mg/mL) 
Lower 95% 
Confidence 
Limit of 
Difference 
(mg/mL) 
Upper 95% 
Confidence 
Limit of 
Difference 
(mg/mL) 
Optiray 
320 9 -23 41 -5 24 
Ethanol 288 235 341 264 312 
K2HPO4 26 -12 64 9 43 
10 gm% 
K2HPO4 
Solution 
109 88 129 99 118 
3.1.1.2.2. SECT Linearity 
The magnitude of each source of variation in an SECT measurement of a 
representative solute concentration is summarized as a CV in Table 5 and Table 6. As with 
DECT concentration measurements, the largest variation observed relative to the mean 
concentration was in HU measurements made in ethanol syringe-phantoms.  
 
Table 5: Calculated sources of variation of a CT number measurement in air at 120 kVp for a 
25% concentration. The mean value and CV of the total variation are also shown for reference. 
The total variation is the sum of the individual variabilities added in quadrature. 
120 kVp Variation (Air) Optiray 25% (HU) 
Ethanol 25% 
(HU) 
K2HPO4 25% 
(HU) 
10 gm% K2HPO4 
Solution 25% (HU) 
Phantom Preparation (σp) 11 - 10 - 
Image to Image (σi) 12 34 10 7 
Scan to Scan (σr) 9 - 2 1 
ROI Noise (σn) 56 1 8 1 
Total (σt) 59 34 16 7 
Mean Value 2144 -28 813 122 
CV (Unitless) 3% -120% 2% 5% 
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Table 6: Calculated sources of variation of a CT number measurement in air at 80 kVp for a 
20% concentration. The mean value and CV of the total variation are also shown for reference. 
The total variation is the sum of the individual variabilities added in quadrature. Calculation of 
the phantom preparation and repeat variation for Optiray 25% was not possible because the 
CT number reached its maximum value so 20% concentrations were evaluated. 
80 kVp Variation (Air) 
Optiray 
20% (HU) 
Ethanol 
20% (HU) 
K2HPO4 20% 
(HU) 
10 gm% K2HPO4 Solution 
20% (HU) 
Phantom Preparation (σp) - - 12 - 
Image to Image (σi) 23 14 13 7 
Scan to Scan (σr) - - 3 1 
ROI Noise (σn) 37 2 8 1 
Total (σt) 43 14 20 7 
Mean Value 2789 -25 930 188 
CV (Unitless) 2% -58% 2% 4% 
 
Like DECT concentration, SECT HU was found to be positively correlated with the 
concentration of all solutes at 120 kVp (R2 > 0.988) (Figure 10, Table 7) and 80 kVp (R2 > 
0.913) (Figure 11, Table 8). At 80 kVp, the HU of the Optiray 320 solutions reached the 
maximum value the software could record (3071), resulting in a weaker linear correlation. 
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Figure 10: Correlation of HU measurements on images acquired using SECT at 120 kVp in air 
with the normalized known concentration. The known concentration was normalized according 
to the formula (value - minimum concentration)/(maximum concentration - minimum 
concentration). Error bars indicate total variation for each measurement but are too small to be 
visible for most measurements. The dotted lines represent the 95% confidence limits for each 
regression fit to the data. 
 
Table 7: Pearson’s correlation coefficients (squared) for correlation of HU measurements on 
images acquired using SECT at 120 kVp and the known concentration of each solute. 
Solute R2 
Optiray 320 0.988 
Ethanol 0.997 
K2HPO4 0.998 
10 gm% K2HPO4 Solution 0.995 
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Figure 11: Correlation of HU measurements on images acquired using SECT at 80 kVp in air 
with the normalized known concentration. The known concentration was normalized according 
to the formula (value - minimum concentration)/(maximum concentration - minimum 
concentration). Error bars indicate total variation for each measurement but are too small to be 
visible for most measurements. The dotted lines represent the 95% confidence limits for each 
regression fit to the data. 
 
Table 8: Pearson’s correlation coefficients (squared) for correlation of HU measurements on 
images acquired using SECT at 80 kVp and the known concentration of each solute. 
Solute R2 
Optiray 320 0.913 
Ethanol 0.996 
K2HPO4 0.998 
10 gm% K2HPO4 Solution 0.994 
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3.1.1.2.3. DXA Linearity 
The magnitude of each source of variation for a syringe-phantom measured with DXA 
aBMD is summarized for a representative solute concentration in Table 9. The variation in 
phantom preparation, though small, is a larger source of variation than the variation between 
scans. 
 
Table 9: Calculated sources of variation of a DXA aBMD measurement for a 25% 
concentration. The mean value and CV of the total variation are also shown for reference. The 
total variation is the sum of the individual variabilities added in quadrature. 
DXA Variation Optiray 25% (aBMD) 
Ethanol 25% 
(aBMD) 
K2HPO4 25% 
(aBMD) 
10 gm% 
K2HPO4 
Solution 25% 
(aBMD) 
Phantom Preparation (σp) 0.03 - 0.02 - 
Scan to Scan (σr) 0.01 - 0.01 0.001 
Total (σt) 0.03 - 0.02 0.001 
Mean Value 5.41 0.064 1.26 0.272 
CV 1% - 2% 0% 
 
The aBMD measured by DXA was also found to be correlated with solute concentration 
for all materials (R2 > 0.880) (Figure 12, Table 10). The correlation was weakest for ethanol. 
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Figure 12: Correlation of aBMD measured by DXA with the known normalized concentration of 
each solute. The known concentration was normalized according to the formula (value - 
minimum concentration)/(maximum concentration - minimum concentration). Error bars indicate 
total variation for each measurement but are too small to be visible for most measurements. 
The dotted lines represent the 95% confidence limits for each regression fit to the data. 
 
Table 10: Pearson’s correlation coefficients (squared) for correlation of aBMD measured by 
DXA with the known concentration of each solute. 
Solute R2 
Optiray 320 0.990 
Ethanol 0.851 
K2HPO4 0.999 
10 gm% K2HPO4 Solution 0.933 
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3.1.1.3. Discussion 
All measurement methods had less variation in the Optiray 320 phantom preparation 
than in K2HPO4 phantom preparation. This result is not surprising when considering the 
different preparation methods (Section 3.1.1.1). There was uncertainty introduced in the 
K2HPO4-water syringe-phantoms in the weighing of the K2HPO4 and additional uncertainty 
introduced during the pipetting of the water and the transfer of the K2HPO4 powder to the water. 
In contrast, uncertainty was introduced in the Optiray 320 syringe-phantom preparation only 
during the pipetting of the Optiray 320 and pipetting of the water; that is, there were fewer 
sources of uncertainty.  
The material density image-derived concentration measurements were well correlated 
and increased linearly with the known solute concentration (Figure 8). SECT and DXA 
measurements also showed a strong linear correlation. While material density image 
measurements of syringe-phantoms containing Optiray 320 and K2HPO4 coarsely followed the 
line of equivalence (intercept consistent with zero and slope only marginally different than 
unity), those for syringe-phantoms containing ethanol were substantially less accurate. 
Measurements of ethanol concentration in ethanol-water syringe-phantoms, though linear, had 
a very large RMS error (289 mg/mL) (Table 3) and offset; indeed, a large concentration of 
ethanol (260 ± 40 mg/mL) was measured even in the 0% concentration syringe-phantom, 
where only distilled water was present. The ethanol-water syringe-phantoms, as well as the 10 
gm% K2HPO4 solution syringe-phantoms, also had relatively large biases (Table 4). 
Distinguishing between ethanol and water is evidently problematic for the material density 
decomposition feature of the GSI Viewer software. This may be explained by the very similar 
mass attenuation coefficients of water and ethanol within the energy range of rsDECT x-rays 
(Figure 13). The effective energy of the 80 and 140 kVp beams used in the DECT acquisitions 
with the medium body filter are roughly 40 and 50 keV. The mass attenuation coefficients of 
water and ethanol are 0.268 g/cm2 and 0.243 g/cm2 at 40 keV and 0.227 g/cm2 and 0.216 
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g/cm2 at 50 keV respectively. In comparison, the mass attenuation coefficient of K2HPO4 is 
0.933 g/cm2 at 40 keV and 0.557 at 50 keV g/cm2. 
Due to the poor results with the ethanol-water syringe-phantoms and basis pair, these 
data were excluded from further investigation in this paper. 
The large average RMS error for all solutes, even those in syringe-phantoms not 
containing ethanol (Table 3), reduces confidence in absolute DECT concentration 
measurements. The large RMS error for two-material phantoms of known suggests that 
measurements of bone material, where the exact composition of trabecular bone varies from 
patient to patient, would almost certainly see errors in accuracy greater than 5%.  
 
Figure 13: Mass attenuation coefficient of water, ethanol, and K2HPO4 from 10-200 keV, with 
the ordinate on a base 10 logarithmic scale. Data taken from NIST XCOM database (109). The 
effective energies of the two beams used in DECT mode (roughly 40 and 50 keV) are 
indicated. 
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3.1.2. Differing Scan Parameters 
3.1.2.1. Materials and Methods 
To investigate the effect of various scanning conditions on the accuracy of material 
density image concentration measurements, further scans of the 28 syringe-phantoms were 
obtained under a variety of conditions: 1) using different a different GSI protocol, 2) in different 
scattering conditions, and 3) at a location away from isocenter.  
Depending on patient size, a different GSI protocol may be indicated for a hypothetical 
DEQCT BMD evaluation. To assess the effect of the GSI protocol, we scanned each syringe-
phantom with the GSI-5 protocol, which differs from the GSI-6 protocol in the bowtie filter used 
and estimated CTDIvol (Table 11).  
 
Table 11: Comparison of GSI protocols assessed in Section 3.1.2. 
Protocol Type Bowtie Filter Size 
Tube Rotation 
Time 
Beam width 
 
Estimated 
CTDIvol 
GSI-6 Body Medium 1 s 40 mm (Axial) 33.43 mGy 
GSI-5 Body Large 1 s 40 mm (Axial) 32.01 mGy 
 
Differences in patient morphology and scan setup may translate into different placement 
of the lumbar spine relative to isocenter of the DECT scanner in a clinical examination. 
Likewise, all clinical QCT measurements of vBMD are made not in air but in scattering 
conditions created by the soft tissue of the patient. To assess the effect of patient positioning, 
each syringe-phantom was scanned in air with the central bore of the electron density body 
phantom set 10.5 cm above isocenter (Figure 14) and compared the measurements to those 
made with the syringe-phantom set at isocenter. To assess the effects of homogenous 
scattering conditions, the portion of the syringe-phantom containing the two-material solution 
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was placed within the central bore of the electron density body phantom while the surrounding 
bores were filled with either water-filled 60 mL syringes or water-equivalent inserts (Figures 16-
17). To assess the effects of heterogeneous scattering conditions, the surrounding bores were 
filled with water-equivalent or various tissue-equivalent inserts included with the phantom 
ranging from lung equivalent (inspiration) to cortical bone equivalent (about -810 to 910 HU at 
120 kVp) (Figure 17).  
In a clinical environment, the weight of different patients varies greatly or the same 
patient may vary in weight between exams. To assess the effect of homogenous scattering 
conditions in a smaller-sized scattering environment, the head insert (7.1 in. (18 cm) diameter) 
was removed from the surrounding body (13 in. x 2 in. x 10.6 in.) of the electron density 
phantom and the associated bores were filled with either syringes containing water or water-
equivalent inserts (Figure 18).  
All scattering-condition measurements were made using the GSI-6 protocol. For 
comparison, sequential axial 120 kVp/150 mA and 80 kVp/200 mA SECT scans with a 1s tube 
rotation time and using the medium body filter were acquired immediately following each DECT 
scan in the various scattering conditions. It was hypothesized that measurements made in 
scattering conditions would have different variabilities than those made in air so a 
reassessment of all sources of variation was performed of the syringe-phantoms in 
homogenous scattering conditions in the body phantom using the same methods as previously 
outlined in Section 3.1.1.1 (the same syringe-phantoms were used to assess phantom 
preparation variation). The variation for measurements made in all scattering conditions was 
estimated with the new total variabilities L. 
  
Figure 14: On and off-isocenter measurements with DECT. 
protrudes in air from the central bore of the electron density
10.5 cm above isocenter.  Right: 120 kVp image of a K
above isocenter. 
Figure 15: Configuration of materials used for DECT
conditions. The syringe-phantom
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Figure 18: DECT and SECT measurements in smaller-sized homogenous scattering 
conditions. Left: The outer body portion of the electron density phantom was removed and 
water-equivalent inserts or 60 mL syringes filled with distilled water were placed within all but 
the central bore of the water-equivalent electron density phantom to perform measurements of 
each two-material syringe-phantom. Right: 120 kVp image of a K2HPO4 syringe-phantom in the 
head portion of the electron density phantom. Due to the display field of view used, the image 
here looks similar to the image for homogenous scattering conditions in the body phantom. 
 
The derived solute concentration or HU for each set of measurements was compared to 
the original concentration or HU measurement in air obtained in Section 3.1.1.2. A linear 
regression was applied to determine the slope and y-intercept with 95% confidence intervals of 
the correlation. Regressions with a y-intercept consistent with 0 within 95% confidence limits 
were re-fit with a y intercept equal to 0. The Pearson’s correlation coefficient was also derived 
for each fit. 
3.1.2.2. Results 
The magnitude of each form of variation in DECT and SECT for each set of syringe-
phantoms in homogenous scattering conditions is summarized for a representative 
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concentration in Table 12 and Tables 13-14 respectively.  In general, all sources of variation 
were greater in scatter. 
 
Table 12: Calculated sources of variation of a solute concentration measurement in scattering 
conditions by DECT for a 25% concentration. The mean value and CV of the total variation are 
also shown for reference. The total variation is the sum of the individual variabilities added in 
quadrature. 
DECT Variation (Scatter) 
Optiray 
25% 
(mg/mL) 
Ethanol 25% 
(mg/mL) 
K2HPO4 25% 
(mg/mL) 
10 gm% 
K2HPO4 
Solution 25% 
(mg/mL) 
Phantom Preparation (σp) 1 - 16 - 
Image to Image (σi) 3 39 6 12 
Scan to Scan (σr) 3 - 21 23 
ROI Noise (σn) 5 314 13 97 
Total (σt) 8 316 30 100 
Mean Value 242 377 378 687 
CV 3% 84% 8% 15% 
 
Table 13: Calculated sources of variation of a CT number measurement in scattering conditions 
at 120 kVp for a 25% concentration. The mean value and CV of the total variation are also 
shown for reference. The total variation is the sum of the individual variabilities added in 
quadrature. 
120 kVp Variation 
(Scatter) 
Optiray 25% 
(HU) 
Ethanol 
25% (HU) 
K2HPO4 
25% (HU) 
10 gm% K2HPO4 
Solution 25% (HU) 
Phantom 
Preparation (σp) 8 - 12 - 
Image to Image (σi) 14 2 6 2 
Scan to Scan (σr) 6 - 10 1 
ROI Noise (σn) 30 17 18 16 
Total (σt) 34 17 25 16 
Mean Value 1491 -33 577 69 
CV 2% -52% 4% 24% 
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Table 14: Calculated sources of variation of a CT number measurement in scattering conditions 
at 80 kVp for a 25% concentration. The mean value and CV of the total variation are also 
shown for reference. The total variation is the sum of the individual variabilities added in 
quadrature. 
80 kVp Variation (Scatter) Optiray 20% (HU) 
Ethanol 
20% (HU) 
K2HPO4 20% 
(HU) 
10 gm% 
K2HPO4 
Solution 20% 
(HU) 
Phantom Preparation (σp) 8 - 23 - 
Image to Image (σi) 17 3 6 3 
Scan to Scan (σr) 9 - 13 1 
ROI Noise (σn) 38 24 30 24 
Total (σt) 43 25 40 24 
Mean Value 1965 -33 643 111 
CV 2% -74% 6% 21% 
 
Material density image concentration measurements with the two different scan 
protocols were correlated, (R2 > 0.999) and when fit to a straight line yielded an offset 
consistent with 0 and a slope near unity (0.960 ± 0.005) (Figure 19, Table 15). Similarly, 
material density image concentration measurements with the phantom placed on and off 
isocenter were correlated (R2 > 0.999) and when fit to a straight line also yielded an offset 
consistent with 0 and a slope near unity (0.954 ± 0.004) (Figure 20). Both scenarios yielded 
statistically significant differences from identity, but the effect was relatively small (< 5% 
discrepancy). 
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Figure 19: Comparison of material density image concentration measurements performed 
using the GSI-5 and GSI-6 protocols. Error bars on the x and y axis indicate total variation for 
measurements made using GSI-6 and GSI-5 protocols respectively and aren’t visible for most 
points.  
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Figure 20: Comparison of material density image concentration measurements performed at 
isocenter and 10.5 cm above isocenter. Error bars on the x and y axis indicate total variation for 
measurements made on and displaced from isocenter respectively and aren’t visible for most 
points. All measurements were made using the GSI-6 protocol. 
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Table 15: Slope and y-intercept with 95% confidence intervals and squared Pearson’s 
correlation coefficient for the linear regression comparing material density image concentration 
measurements acquired using GSI-5/6 protocols and on/10.5 cm above isocenter. The y-
intercept with 95% confidence intervals was equivalent to 0 in the original regression in both 
cases, so the data were re-fit with a regression set to intercept the y-axis at y = 0 mg/mL. The 
probability of the slope of this regression being equivalent to unity was evaluated with an f-test. 
Significance in this experiment was defined as p < 0.05. 
Regression Slope R2 y-Intercept (mg/mL) Slope (Intercept = 0) p (slope = 1) 
GSI-5 vs. 
GSI-6 0.955 ± 0.008 >0.999 4 ± 5 0.960 ± 0.005 <0.0001 
Off vs. On-
Isocenter 0.957 ± 0.006 >0.999 -2 ± 4 0.954 ± 0.004 <0.0001 
 
Scattering conditions severely (by ~26%) reduced the material density image-derived 
concentration compared to measurements made in air (Figure 21, Table 16). The effect of 
heterogeneous scattering conditions was not significantly different from homogenous scattering 
conditions (< 1% difference). The effect of scatter in the head phantom was far less 
pronounced, but still significant (~8% reduction from in-air measurements). In comparison, the 
presence of scattering material also decreased the CT number relative to air at 120 (slope = 
0.70 ± 0.01) and 80 kVp (slope = 0.75 ± 0.04) (Figure 22, Table 17). Again the difference 
between measurements made in heterogeneous and homogenous scattering conditions was 
not significant. Measurements made in the head insert did not differ as much as in the body 
phantom when compared to air (slope = 0.834 ± 0.007 at 120 and 0.93 ± 0.04 at 80 kVp). 
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Table 16: Slope and y-intercept with 95% confidence intervals and squared Pearson’s 
correlation coefficient for the linear regression comparing material density image concentration 
measurements made in air and in various scattering conditions. The y-intercept with 95% 
confidence intervals was equivalent to 0 in the original regression in all cases, so the data were 
re-fit with a regression set to intercept the y-axis at y = 0. Significance in this experiment was 
defined as p < 0.05.Note: Hom. = homogenous, Het. = heterogeneous. 
DECT Regression Slope R2 y-Intercept (mg/mL) 
Slope 
(Intercept = 0) p (slope = 1) 
Hom. Scatter vs. Air 0.75 ± 0.03 0.994 -14  ± 17 0.74 ± 0.02 < 0.0001 
Het. Scatter vs. Air 0.76 ± 0.02 0.996 -10  ± 14 0.75± 0.01 < 0.0001 
Small Hom. Scatter vs. 
Air 0.92 ± 0.02 0.998 -7  ± 13 0.91 ± 0.01 < 0.0001 
 
 
Figure 21: Comparison of material density image concentration measurements acquired in air 
and in different scattering conditions. Error bars on the x and y axis indicate total variation for 
measurements made in air and in scattering conditions respectively. The line of equivalence is 
shown for reference. 
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Figure 22: Comparison of SECT HU measurements acquired in air and in different scattering 
conditions at 120 and 80 kVp. Error bars on the x and y axis indicate total variation for 
measurements made in air and in scattering conditions respectively. The line of equivalence is 
shown for reference. 
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Table 17: Slope and y-intercept with 95% confidence intervals and the squared Pearson’s 
correlation coefficient for the linear regression comparing SECT concentration measurements 
made in air and in various scattering conditions at 120 and 80 kVp. The y-intercept with 95% 
confidence intervals was equivalent to 0 in the original regression in homogenous and 
heterogeneous scattering conditions in the body phantom at 80 kVp, so the data were re-fit with 
a regression set to intercept the y-axis at y = 0 HU. Note: Hom. = homogenous, Het. = 
heterogeneous. 
SECT Regression Slope R2 y-Intercept (HU) 
Slope 
(Intercept = 0) p (slope = 1) 
Hom. Scatter vs. Air 
(120 kVp) 0.70 ± 0.01 0.999 -14 ± 10  <0.0001 
Hom. Scatter vs. Air 
(80 kVp) 0.79 ± 0.05 0.984 -60 ± 70 0.75 ± 0.04 <0.0001 
Het. Scatter vs. Air 
(120 kVp) 0.71 ± 0.01 0.999 -15 ± 11  <0.0001 
Het. Scatter vs. Air 
(80 kVp) 0.77 ± 0.04 0.982 -60 ± 60 0.77 ± 0.04 <0.0001 
Small Hom. Scatter 
vs. Air (120 kVp) 0.834 ± 0.007 >0.999 -11 ± 7  <0.0001 
Small Hom. Scatter 
vs. Air (80 kVp) 0.93 ± 0.04 0.994 -50 ± 49  0.0012 
 
For the remainder of this paper, when assessing the effects of scatter on DECT and SECT 
measurements, we explored only homogenous scattering conditions in the body phantom. 
Figures 24-28 illustrate the magnitude of each source of variation for each measurement 
method as an average CV of the mean measurement across all concentrations. Figure 23 
illustrates the magnitude of the total variation for each measurement method. The magnitude of 
every type of variation is highest in DECT and SECT measurements in scattering conditions 
and for ethanol. 
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Figure 23: Variation between scans as an average CV of the mean measurement assessed in 
DECT, SECT, and DXA for Optiray 320, K2HPO4, and 10 gm% K2HPO4 solution syringe-
phantoms. 
 
Figure 24: Variation between images as an average CV of the mean measurement assessed in 
DECT and SECT for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringe-
phantoms. The very large CV for ethanol measured in air at 120 kVp is mostly due to the 
relatively small mean value in the denominator. 
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Figure 25: Variation in known concentration from phantom preparation as an average CV of the 
mean measurement assessed in DECT, SECT, and DXA for Optiray 320 and K2HPO4 syringe-
phantoms. 
 
Figure 26: Variation in measured mean as an average CV of the mean measurement assessed 
in DECT and SECT for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringe-
phantoms. 
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
3.50%
4.00%
4.50%
DECT (Air) DECT (Scatter) 120 kVp (Air) 120 kVp 
(Scatter)
80 kVp (Air) 80 kVp (Scatter)
Phantom Preparation Variation σp
Optiray 320
K2HPO4
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
120.00%
DECT (Air) DECT (Scatter) 120 kVp (Air) 120 kVp 
(Scatter)
80 kVp (Air) 80 kVp (Scatter)
ROI Noise σn
Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4 Solution
 55 
 
 
 
 
 
 
 
 
 
 
Figure 27: Total variation as an average CV of the mean measurement assessed in DECT, 
SECT, and DXA for Optiray 320, ethanol, K2HPO4, and 10 gm% K2HPO4 solution syringe-
phantoms. The very large CV for ethanol is partially due to the relatively small mean value in 
the denominator. 
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Table 18 summarizes the scan-to-scan variation p of each measurement method for 
comparison, excluding ethanol due to the large CVs. Variation p is greatest for the DECT 
scanner measurements in scattering conditions (7%), while it is greatest for DXA (0.2%). 
 
 
 
 
Table 18: Variation between scans as an average CV of the mean measurement across all 
syringe-phantoms except for ethanol for DECT, SECT and DXA in air and in scattering 
conditions. 
Measurement Method Scan-to-Scan Variation σr 
DXA 0.2% 
120 kVp Air 0.4% 
-150.0%
-100.0%
-50.0%
0.0%
50.0%
100.0%
150.0%
DECT (Air) DECT 
(Scatter)
120 kVp (Air) 120 kVp 
(Scatter)
80 kVp (Air) 80 kVp 
(Scatter)
DXA
Total Variation σt
Optiray 320
Ethanol
K2HPO4
10 gm% K2HPO4 Solution
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80 kVp Air 0.4% 
DECT Air 0.8% 
80 kVp Scatter 1% 
120 kVp Scatter 1% 
DECT Scatter 7% 
3.1.2.3. Discussion 
 While the effects of the GSI protocol used and position relative to isocenter produced 
only small (< 5%) reductions (Table 15), the large reductions (~9-26%) (Table 16) in material 
density image-derived concentrations obtained in scattering conditions indicates sensitivity of 
these measurements to scan conditions. The reductions seem to correlate with the amount of 
scattering material surrounding each syringe-phantom. Because the amount of soft tissue 
attenuation will vary between patients, or a single patient may have different amounts of tissue 
at different time points due to weight loss or gain, the observed variation in GSI values with 
phantom size may be problematic for clinical interpretation. While dual-energy x-ray imaging 
would ideally compensate for effects such as the amount of non-bone tissue, beam hardening, 
and scatter, its similarity in behavior to SECT suggest certain limitations in the preprocessing 
algorithm used in the GSI Viewer software. Because the indicated protocol and anatomic 
positioning will differ for each patient in a clinical situation, the observed differences between 
measurements made on and off isocenter and between GSI protocols contribute to the poor 
accuracy, although their effect is relatively small. 
Comparing the sources of variation in air and in scattering conditions, the variation 
between scans was smallest for DXA (Table 9), indicating it has the most stability between 
scans of the three measurement methods. DXA is known to have a low variation between 
scans, which is an important reason for its status as the gold standard of bone mineral 
assessment (74). In scattering conditions, DECT measurements had a relatively high variation 
between scans and in scatter had the highest of the measurement methods assessed, 
suggesting a potential problem for the use of DECT measurements in screening for bone 
mineral loss. Because DECT data is derived from two sets of single-energy data, the sources 
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of variation in each beam may act in a cumulative fashion to decrease the precision of DECT. 
There is also likely to be additional variation introduced in the preprocessing basis pair 
computations. 
3.2. Subaim 2: Measurements in Bone Geometry Models 
3.2.1. Concentric Phantom Accuracy 
3.2.1.1. Materials and Methods 
The objective of this study was to assess the performance of the material density 
images when imaging phantoms that model the geometry of human bones. Concentric 
phantoms were constructed and scanned to ascertain if there were differences in material 
density image-derived concentrations under bone-like conditions relative to uniform syringe-
phantoms. Thirteen concentric phantoms were prepared, consisting of a 5 mL cylindrical plastic 
vial (diameter = ½ in. or 1.3 cm) containing a solution of K2HPO4 in water placed inside a 50 mL 
plastic centrifuge tube (diameter = 3.0 cm) containing Optiray 320 solution. The less-
attenuating inner solution of K2HPO4 was constructed to simulate trabecular bone, while the 
more-attenuating outer solution of Optiray 320 was constructed to simulate cortical bone.  Two 
sets of concentric phantoms were created, each designated as (X%/Y%) where X is the 
concentration by volume of K2HPO4 in the inner chamber and Y is the concentration by volume 
of Optiray 320 in the outer chamber, as per Table 19 and Figure 28. One set was constructed 
with the concentration of the inner solution fixed at 10% by volume and the concentration of the 
outer solution increasing in increments of 5% per volume from 0-30% and the other with the 
outer solution fixed and the inner solution increasing in concentration. Two concentric 
phantoms (0%/0%, containing only water in each chamber, and 10%/10%) were shared 
between the sets. Dual and single-energy scans were acquired with the concentric phantom 
placed in the electron density body phantom in air and in scattering conditions as described in 
Section 3.1.1.1 (Figure 29). Measurements of the average concentration and HU were made 
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using the GSI Viewer software with circular ROIs drawn within the cross-section of the inner 
cylindrical volume (44-47 mm2) and the within the annular cross-section of the outer cylindrical 
volume (19-23 mm2) (Figure 30). In addition, each concentric phantom was scanned in the 
DXA scanner using the same methodology as described in Section 3.1.1.1, with rectangular 
ROIs drawn on area corresponding to the inner and outer solution (Figure 31) 
 
Table 19: Description of concentric phantoms constructed for concentric phantom experiments. 
Each value is represented as a percent by volume concentration formatted as concentration of 
K2HPO4 by volume/concentration of Optiray 320 by volume. The 0%/0% concentric phantom 
contains only water in the inner and outer chambers. The 0%/0% and 10%/10% concentric 
phantoms were shared between the two sets. 
K2HPO4/ 
Optiray 
320 
0%/0% 
5%/10% 
10%/10% 
15%/10% 20%/10% 25%/10% 30%/10% 
K2HPO4/ 
Optiray 
320 
10%/5% 10%/15% 10%/20% 10%/25% 10%/30% 
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Figure 28: Diagram describing the two sets of concentric phantoms constructed for Section 
3.2.1. The color blue represents Optiray 320 solution and the color green represents K2HPO4 
solution. The increasing concentration of the solute is represented by the darkening hue of 
each color. The simplified diagrams on the far right illustrate for which solution the 
concentration was increased and for which solution the concentration remained fixed in each 
set. 
 
Figure 29: Configuration of materials for concentric phantom DECT and SECT measurements 
in air (left) and in scattering conditions (right). 
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Figure 30: Example GSI Viewer in-air measurements of the K2HPO4 concentration in the inner 
circular area and the Optiray 320 concentration in the annular area surrounding. The Optiray 
320-water basis pair is used in this illustration. 
 
Figure 31: Left: Placement of concentric phantoms for DXA scanning. Right: Rectangular ROIs 
drawn on DXA image of concentric phantoms for the inner and outer chambers. 
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For both the outer and inner solution, the measured concentration, HU, or aBMD was 
plotted against the measurement made in the uniform syringe-phantom with the equivalent 
concentration (but not the exact same solution). The data were fit with a linear regression and 
the slope with 95% confidence intervals was compared with an expected value of either 1 or 0 
with an f-test.  Regressions with a y-intercept consistent with 0 within 95% confidence limits 
were re-fit with a y intercept equal to 0. To produce error bars on the y-axis, an estimate of the 
total variation L of the concentric measurements was assessed with the CV between images 
o, phantom preparation M, and variation between scans p were taken from the uniform 
syringe-phantom data and the noise a was taken from measurements made in the individual 
concentric phantoms. 
3.2.1.2. Results 
3.2.1.2.1 DECT Concentric Phantom Accuracy 
Most of the slopes measured did not vary significantly (p < 0.5) from their expected 
value of unity or 0 (Table 20, Figures 33-34). The measured concentration of K2HPO4 in the 
inner chamber, while a fixed concentration of Optiray 320 was present in the outer chamber, 
was higher by ~13% in air than those measured for the uniform K2HPO4 phantom (Figure 32, 
top). The measured concentration of Optiray 320 in the outer chamber, while a fixed 
concentration of K2HPO4 was present in the inner chamber, was lower by ~12% than measured 
in the uniform Optiray 320 phantom (Figure 33, top). Most notably, however, the K2HPO4 
concentration increased in the phantoms in which the K2HPO4 concentration was fixed and the 
Optiray 320 concentration increased (Figure 33, bottom) both in air and in scattering conditions. 
The in-air measured concentration of K2HPO4 ranged from 276 mg/mL—399 mg/mL while the 
expected concentration based on in-air measurement in the uniform 10% K2HPO4 syringe-
phantom was just 258 ± 6 mg/mL. 
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Figure 32: Material density image concentration measurements in air and scattering conditions 
of concentric phantoms where the inner K2HPO4 solution concentration increases and the outer 
Optiray 320 solution concentration is fixed. Error bars on the x-axis and y-axis indicate the total 
variation of the uniform solution measurement and the measurement made in the concentric 
phantom, respectively. Top Left: Measurements of K2HPO4 concentration. A slope of 1 is 
expected for both measurements; in-air measurements yielded a slope of 1.13 ± 0.03 and 
scatter measurements yielded a slope of 1.08 ± 0.08. Bottom Left: Measurements of Optiray 
320 concentration. A slope of 0 is expected for both measurements; in-air and scatter 
measurements both yielded a slope of -0.01 ± 0.04. Right: Graphic based on Figure 28 
illustrating which solution concentration is changing, which solution concentration is fixed, and 
which is being plotted to the left (arrow). 
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Figure 33: Material density image concentration measurements in air and scattering conditions 
of concentric phantoms where the inner K2HPO4 solution concentration is fixed and the outer 
Optiray 320 solution concentration increases. Error bars on the x-axis and y-axis indicate the 
total variation of the uniform solution measurement and the measurement made in the 
concentric phantom, respectively. Top Left: Measurements of Optiray 320 concentration. A 
slope of 1 is expected for both measurements; in-air measurements yielded a slope of 0.88 ± 
0.03 and scatter measurements yielded a slope of 1.01 ± 0.04. Bottom Left: Measurements of 
K2HPO4 concentration. A slope of 0 is expected for both measurements; in-air measurements 
yielded a slope of 0.3 ± 0.1 and scatter measurements yielded a slope of 1.1 ± 0.4.  Right: 
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution 
concentration is fixed, and which is being plotted to the left (arrow).  
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Table 20: Slope with 95% confidence intervals compared for a regression of the concentration 
measured in the concentric phantom vs the concentration measured in the uniform syringe-
phantom. Each concentric phantom was scanned both in air and in scattering conditions and 
compared with the uniform syringe-phantom with both the equivalent concentration of K2HPO4 
and Optiray 320 in those conditions. When the concentration of the material analyzed was 
fixed, it was expected that the slope of the regression would be 0. When the concentration of 
the material analyzed was changing, it was expected that the slope of the regression would be 
unity. Slopes considered different from expectation are marked with a *. 
Material 
Analyzed 
(mg/mL) 
Fixed 
Material 
Changing 
Material 
Corresponding 
Figure Slope Expected 
K2HPO4  
(Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 33 
(Bottom) 0.3 ± 0.1* 0 
K2HPO4 
(Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 33 
(Bottom) 1.1  ± 0.4* 0 
Optiray 
 (Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 33 
 (Top) 0.88 ± 0.03* 1 
Optiray 
(Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 33 
 (Top) 1.01  ± 0.04 1 
K2HPO4  
(Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 32 
(Top) 1.13 ± 0.03* 1 
K2HPO4 
(Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 32 
(Top) 1.08 ± 0.08 1 
Optiray 
(Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 32 
(Bottom) -0.01 ± 0.04 0 
Optiray 
(Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 32 
(Bottom) -0.01  ± 0.04 0 
 
3.2.1.2.2 SECT Concentric Phantom Correlation 
The trends observed in material density image concentration measurements were 
mostly also observed in single-energy HU measurements (Figures 35-36, Table 21). The 
measured in-air CT number of K2HPO4 for a fixed concentration ranged from 390  HU to 547 
HU at 120 kVp and from 535 HU to 772 HU where a value of 398 ± 8 HU and 533 ±11 HU was 
expected respectively (Figure 35, bottom), based on measurements in uniform syringe-
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phantoms. The lower than expected Optiray measurements in concentric phantoms in which 
Optiray was changing was observed at 120 kVp but not at 80 kVp (Figure 35, top). The slightly 
higher K2HPO4 concentration measurements in concentric phantoms where the Optiray 
concentration was held fixed in air was not observed (Figure 34, top). Note that for the 
concentric phantoms measured in air at 80 kVp in which the outer Optiray 320 concentration 
was 25 or 30% (Figure 35, bottom), the HU reached the maximum value the software was 
capable of reporting (3071 HU). 
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Figure 34: SECT HU measurements of concentric phantoms in air and scattering conditions at 
120 and 80 kVp where the inner K2HPO4 solution increases and the outer Optiray 320 solution 
concentration is fixed. Error bars on the x-axis and y-axis indicate the total variation of the 
uniform solution measurement and the measurement made in the concentric phantom, 
respectively. Top Left: Measurements of K2HPO4 HU. A slope of 1 is expected for all 
measurements; in-air measurements at 120 kVp yielded a slope of 0.99 ± 0.02 and scatter 
measurements yielded a slope of 1.01 ± 0.03. In-air measurements at 80 kVp yielded a slope 
of 1.02 ± 0.02 and scatter measurements yielded a slope of 1.03 ± 0.04. Bottom Left: 
Measurements of Optiray HU. A slope of 0 is expected for all measurements; in-air and scatter 
measurements at 120 kVp both yielded a slope of 0.0 ± 0.1. In-air measurements at 80 kVp 
yielded a slope of 0.0 ± 0.1 and scatter measurements yielded a slope of 0.0± 0.2. Right: 
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution 
concentration is fixed, and which is being plotted to the left (arrow). 
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Figure 35: SECT HU measurements of concentric phantoms in air and scattering conditions at 
120 and 80 kVp where the inner K2HPO4 solution is fixed and the outer Optiray 320 solution 
concentration increases. Error bars on the x-axis and y-axis indicate the total variation of the 
uniform solution measurement and the measurement made in the concentric phantom, 
respectively. Top Left: Measurements of Optiray HU. A slope of 1 is expected for all 
measurements; in-air measurements at 120 kVp yielded a slope of 0.94 ± 0.5 and scatter 
measurements yielded a slope of 0.93 ± 0.5. In-air measurements at 80 kVp yielded a slope of 
0.97 ± 0.07 and scatter measurements yielded a slope of 0.97 ± 0.06. Note that for a 30% 
Optiray 320 concentration, the CT number reached a maximum value at 80 kVp in air. Bottom 
Left: Measurements of K2HPO4 HU. A slope of 0 is expected for all measurements; in-air 
measurements at 120 kVp yielded a slope of 0.8 ± 0.3 and scatter measurements yielded a 
slope of 0.9 ± 0.3. In-air measurements at 80 kVp yielded a slope of 0.09 ± 0.06 and scatter 
measurements yielded a slope of 0.12 ± 0.04. Right: Graphic based on Figure 28 illustrating 
which solution concentration is changing, which solution concentration is fixed, and which is 
being plotted to the left (arrow). 
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Table 21: Slope with 95% confidence intervals compared for a regression of the HU measured 
in the concentric phantom vs the HU measured in the uniform syringe-phantom in air and in 
scattering conditions at 120 and 80 kVp. Each concentric phantom was scanned both in air and 
in scattering conditions and compared with the uniform syringe-phantom with both the 
equivalent concentration of K2HPO4 and Optiray 320 in those conditions. When the 
concentration of the material analyzed was fixed, it was expected that the slope of the 
regression would be 0. When the concentration of the material analyzed was changing, it was 
expected that the slope of the regression would be unity. Slopes considered different from 
expectation are marked with a *. 
Material Analyzed 
(HU) 
Fixed 
Material 
Changing 
Material Figure Slope Expected 
K2HPO4  
(120 kVp) (Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Bottom) 0.08  ± 0.03* 0 
K2HPO4  
(120 kVp) (Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Bottom) 0.09± 0.03* 0 
K2HPO4  
(80 kVp) (Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Bottom) 0.09 ± 0.06* 0 
K2HPO4  
(80 kVp) (Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Bottom) 0.12 ± 0.04* 0 
K2HPO4  
(120 kVp) (Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Top) 0.99 ± 0.02 1 
K2HPO4 
 (120 kVp) (Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Top) 1.01 ± 0.03 1 
K2HPO4 
 (80 kVp) (Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Top) 1.02 ± 0.02 1 
K2HPO4 
(80 kVp) (Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Top) 1.03 ± 0.04 1 
Optiray 320  
(120 kVp) (Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Bottom) 0.0 ± 0.1 0 
Optiray 320 
(120 kVp) (Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Bottom) 0.0 ± 0.1 0 
Optiray 320 
 (80 kVp) (Air) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Bottom) 0.0 ± 0.1 0 
Optiray 320  
(80 kVp) (Scatter) 
Optiray 320 
(Outer) 
K2HPO4 
(Inner) 
Figure 34 
(Bottom) 0.0 ± 0.2 0 
Optiray 320 
 (120 kVp) (Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Top) 0.94 ± 0.5* 1 
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Optiray 320 
(120 kVp) (Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Top) 0.93 ± 0.05* 1 
Optiray 320  
(80 kVp) (Air) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Top) 0.97 ± 0.07 1 
Optiray 320  
(80 kVp) (Scatter) 
K2HPO4 
(Inner) 
Optiray 320 
(Outer) 
Figure 35 
(Top) 0.97  ± 0.06 1 
 
3.2.1.2.3 DXA Concentric Phantom Correlations 
DXA measurements of concentric phantoms are summarized in Figures 37-38. Similar 
to the trend observed in DECT and SECT, aBMD measurements of K2HPO4 in the inner 
chamber had a positive, nonzero slope (0.58 ± 0.03) despite a fixed concentration (Figure 37, 
bottom, Table 22). This measurement also had a higher offset than expected by about 0.26 
g/cm2. Measurements of Optiray 320 in the outer chamber, conversely, had a lower slope than 
expected when the concentration was increased (Figure 37, top). This was also true of 
measurements of K2HPO4 in the inner chamber while the concentration increased and the 
concentration of the Optiray 320 in the outer chamber remained fixed (Figure 36, top). There 
was also a large offset in this measurement, about 1.3 g/cm2 greater than the expected value 
(0 g/cm2).  The offset for outer chamber Optiray 320 measurements in this set of concentric 
phantoms was less than the expected value by about 0.6 g/cm2 (Figure 36, bottom). 
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Figure 36: DXA aBMD measurements of concentric phantoms where the inner K2HPO4 solution 
increases and the outer Optiray 320
 
solution concentration is fixed. Error bars on the x-axis and 
y-axis indicate the total variation of the uniform solution measurement and the measurement 
made in the concentric phantom, respectively. Top Left: Measurements of K2HPO4 aBMD. A 
slope of 1 and offset of 0 is expected; measurements yielded a slope of 0.4 ± 0.1 and an offset 
of 1.3 ± 0.1. Bottom Left: Measurements of Optiray aBMD. A slope of 0 and offset of 2.58 ± 
0.02 is expected; measurements yielded a slope of -0.1 ± 0.2 and an offset of 2.0 ± 0.2. Right: 
Graphic based on Figure 28 illustrating which solution concentration is changing, which solution 
concentration is fixed and which is being plotted to the left (arrow). 
 72 
 
 
Figure 37: DXA aBMD measurements of concentric phantoms for which the inner K2HPO4 
concentration is fixed and the outer Optiray 320 solution concentration increases. Error bars on 
the x-axis and y-axis indicate the total variation of the uniform solution measurement and the 
measurement made in the concentric phantom, respectively. Top left: Measurements of Optiray 
aBMD. An offset of 0 and slope of 1 is expected; measurements yielded a slope of 0.8 ± 0.1 
and an offset of -0.2 ± 0.5. Bottom left: Measurements of K2HPO4 aBMD. A slope of 0 and an 
offset of 0.592 ± 0.009 is expected; measurements yielded a slope of 0.58 ± 0.03 and an offset 
of 0.85 ± 0.01. Right: Graphic based on Figure 28 illustrating which solution concentration is 
changing, which solution concentration is fixed and which is being plotted to the left (arrow). 
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Table 22: Slope and offsets with 95% confidence intervals compared for a regression of the 
aBMD measured in the concentric phantom vs the aBMD measured in the uniform syringe-
phantom. Each concentric phantom was scanned between eight 3/8 in. (9.5 mm) PMMA blocks 
and compared with the uniform syringe-phantom with both the equivalent concentration of 
K2HPO4 and Optiray 320 in those conditions. When the concentration of the material analyzed 
was fixed, it was expected that the slope of the regression would be 0. When the concentration 
of the material analyzed was changing, it was expected that the slope of the regression would 
be unity. The expected offset is the measurement of the uniform syringe-phantom of equivalent 
concentration to the material being analyzed ± the total variation in the uniform syringe-
phantom measurement or 0 if the material being analyzed is changing in concentration. Slopes 
and offsets considered different from expectation are marked with a *. 
Measurement, 
Phantom 
Corresponding 
Figure Slope 
Expected 
Slope 
Offset 
(g/cm2) 
Expected 
Offset 
(g/cm2) 
K2HPO4 aBMD, 
Optiray Changing 
Figure 37 
(Bottom) 0.58 ± 0.03* 0 0.85 ± 0.01* 0.592 ± 0.009 
Optiray aBMD, 
K2HPO4 Changing 
Figure 36 
(Bottom) -0.1 ± 0.2 0 2.0 ± 0.2* 2.58 ± 0.02 
Optiray aBMD, 
Optiray Changing 
Figure 37 
(Top) 0.8 ± 0.1 1 -0.2 ± 0.5 0 
K2HPO4 aBMD, 
K2HPO4 Changing 
Figure 36 
(Top) 0.4 ± 0.1 1 1.3 ± 0.1* 0 
 
3.2.1.3. Discussion 
In theory, in three-dimensional images of two concentric cylinders each containing two 
materials, the concentration of one material should not affect measurements made in another. 
However, we measured and increasing value in the inner K2HPO4 solution with increasing 
Optiray 320 concentration, despite a fixed composition. The effect appears in both DECT 
(Figure 33, bottom) and SECT (Figure 35, bottom) indicating that, as in the scattering 
conditions experiments in Section 3.1.2, the effect is likely caused by inaccuracies in the DECT 
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material decomposition reconstruction from the single-energy data. Since every line integral 
through this region contains the high attenuation (relative to K2HPO4) from the surrounding 
Optiray 320, the effect may be attributed to limitations in the filtered back-projection used to 
reconstruct the dual and single-energy CT images; that is, some attenuation from Optiray 320 
may have “smeared” across the regions containing K2HPO4. The effect in this case is the 
opposite from what might be expected in a beam hardening artifact, in which the measured 
concentration or HU of the K2HPO4 solution might be expected to be lower than for a uniform 
solution of the same concentration. Back-projection errors may also be responsible for the 
deviation of the slope for the changing Optiray 320 concentration from 1 (Figure 33, Figure 35). 
Higher variation in each measurement compared to in air may mask this effect in scattering 
conditions in DECT. 
It is not clear why in-air DECT concentration measurements of K2HPO4 are greater 
(~13%) when surrounded by a fixed Optiray concentration than those measured in uniform 
phantoms (Figure 32) as the corresponding effect is not present in single-energy data. As for 
the Optiray measurements in increasing Optiray concentrations (Figure 33), the effect may be 
masked in scattering conditions by the greater variation in each DECT measurement compared 
to in air. It is unknown how the GSI Viewer software combines the data from each single-
energy beam. It is possible that while the greater than expected K2HPO4 measurements in a 
changing K2HPO4 concentration are not discernable in single-energy data, there is an 
cumulative effect when constructing dual-energy images. This cumulative effect may also 
explain why the Optiray concentration measurements for a changing Optiray concentration in 
air are lower than expected in DECT and at 120 kVp but not at 80 kVp. 
The DXA measurements of the concentric phantoms demonstrate quantitative 
inaccuracy stemming from signal integration. The concentration of the outer solute was 
expected to contribute to the aBMD of the inner solute measured by DXA and lead to 
inaccurate measurements. Consistent with expectations, although the inner K2HPO4 solution 
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(meant to represent trabecular bone) concentration was held constant, the DXA aBMD 
increased with higher Optiray 320 (meant to represent cortical bone) concentration present in 
the outer chamber (Figure 37, bottom). The integration methodology also causes differences in 
aBMD measurements due to different phantom geometries. DXA measurements of Optiray 320 
aBMD with a changing concentration (Figure 37), even when made without integration through 
a K2HPO4 solution, were less (~20%) than those made with in the uniform syringe-phantoms 
with 95% confidence. This is due to differences in the thickness of the cylinders across the area 
presented to the DXA beam and the different diameter of the concentric vs the uniform syringe-
phantom cylinders (3.0 vs. 2.5 cm). When a DXA measurement is made off the axis of a 
cylinder, the x-ray beam travels through a smaller thickness of the solution compared to a 
measurement made along the axis of the same area, resulting in a smaller average aBMD. The 
same is true for measurements of the same area made in the same location on two cylinders of 
different diameter (Figure 38). 
 
Figure 38: The aBMD varies for the same size and shaped ROI area on a cylinder depending 
on position transverse to the axis and cylinder diameter. 
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3.2.2. Reversed Concentric Phantoms 
3.2.2.1. Materials and Methods 
To further investigate the increasing K2HPO4 measurements for a fixed concentration 
observed in DECT and SECT measurements in Section 3.2.1.2, three additional concentric 
phantoms were constructed with the placement of the K2HPO4 and Optiray 320 solutions 
reversed (Figure 39). The inner 5 mL vial was filled with an Optiray 320 dilution in water with a 
concentration of 10, 20, or 30% by volume and the outer 50 mL centrifuge tube was filled with a 
10% by volume solution of K2HPO4 in water for all three concentric phantoms. Dual and single-
energy CT scans were acquired and analyzed in the same manner as Section 3.2.1.1.  
 
Figure 39: Diagram based on Figure 28 describing the set of three “reverse” concentric 
phantoms constructed for the reversed concentric phantom experiment. The color blue 
represents Optiray 320 solution, while the color green represents K2HPO4 solution. The 
increasing concentration of the Optiray 320 represented by the darkening hue.The simplified 
diagram on the far right illustrates for which solution the concentration was increased and for 
which solution the concentration remained fixed, as in Figure 28. 
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3.2.2.2. Results 
 The results for DECT are summarized in Figure 40 and SECT in Figure 41. To produce 
error bars on the y-axis, an estimate of the total variation L of the concentric measurements 
was assessed with the CV between images o, phantom preparation M, and variation between 
scans p were taken from the uniform syringe-phantom data and the noise a was taken from 
the measurement made in the individual reversed concentric phantoms. The Optiray solution 
with a nominal concentration of 20% by volume appears to have been prepared incorrectly; 
nonetheless, a general trend is apparent. In every plot the measured concentration and HU of 
the Optiray 320 solution is increasing with concentration while the measured value of the 
K2HPO4 solution remains relatively fixed.  
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Figure 40: Left: Material density image concentration measurements in air (Top) and in 
scattering conditions (Bottom) of the inner Optiray 320 solution of increasing concentration, 
where the outer K2HPO4 solution concentration was fixed. Error bars on the x-axis and y-axis 
indicate the total variation of the uniform solution measurement and the measurement made in 
the concentric phantom, respectively. The point corresponding to 20% Optiray concentration 
appears to reflect an improper Optiray solution preparation. Right: Graphic based on Figure 39 
illustrating which solution concentration is changing, which solution concentration is fixed and 
which is being plotted to the left (arrow). 
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Figure 41: Left: SECT HU measurements in air (Top) and in scatter (Bottom) at 120 and 80 kVp 
of the inner Optiray 320 solution of increasing concentration, where the outer K2HPO4 solution 
concentration was fixed. Error bars on the x-axis and y-axis indicate the total variation of the 
uniform solution measurement and the measurement made in the concentric phantom, 
respectively. The points corresponding to 20% Optiray concentration appears to reflect an 
improper Optiray solution preparation. Right: Graphic based on Figure 39 illustrating which 
solution concentration is changing, which solution concentration is fixed and which is being 
plotted to the left (arrow).  
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3.2.2.3. Discussion 
 The increasing concentration and HU measurements of a fixed K2HPO4  solution with 
increasing Optiray 320 concentration disappears when the relative position of the two solutions 
in the concentric phantoms is reversed and the measurements are instead stable. This 
indicates that the effect is geometrically dependent rather than an inherent property of the two 
materials or the scanner. When the position of the Optiray 320 solution and the K2HPO4 
solution were reversed in the concentric geometry, the effect probably disappeared because 
many fewer line integrals containing K2HPO4 also contained Optiray 320. The Optiray 320 
concentration increases as expected. 
3.3. Subaim 3: Sensitivity of Measurement Methods 
3.3.1. Materials and Methods 
It is important for any measurement method used for BMD screening to be sensitive to 
very small changes in bone density so that the screening is able to detect changes early 
enough for preventative treatment. To compare the sensitivity of each measurement method, a 
series of thirteen syringe-phantoms were prepared in 60 mL syringes containing 30 mL K2HPO4 
solutions with concentrations by volume varying by 5/2x%, where x = 0 – 12. That is, percent 
concentration successively varied as a half of the previous concentration, 5%, 2.5%, 1.25%, 
etc. Because the excess volume from the K2HPO4 was too small to be evaluated from the 
syringes, a quadratic regression was fitted to the table provided in Rao et al. (107) of water 
concentration with increasing K2HPO4 concentration. An additional 30 mL syringe-phantom 
containing pure distilled water (0% concentration) was prepared. Measurements of the K2HPO4 
solutions were acquired on three separate dates with SECT and DECT in air and in scattering 
conditions and with DXA as described in Sections 3.1.1.1 and  3.1.2.1 and the three 
measurements were averaged.  
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For this experiment, it was necessary to create a new estimate of total variation L for 
each averaged measurement. Variation in phantom preparation, M, was assumed to be the 
same value as calculated previously for K2HPO4. Variation between images, o, was estimated 
from a stack of images obtained of a 2.5% K2HPO4 syringe-phantom in air and scattering 
conditions using the method in section 3.1.1.1 and 3.1.2.1. Variation between scans, p, was 
the standard deviation of the three-measurement mean. The noise, a, of each measurement 
was taken as the average standard deviation of the mean for each concentration. The total 
standard deviation L was obtained by summing the four variabilities in quadrature. 
Two different tests assessing the sensitivity of each measurement method were 
established. In the first test, the difference   Z ' r was considered, where Z is the 
measurement of a given K2HPO4 concentration and r is the measurement for pure water. The 
standard deviation of the difference  is defined by the propagation of error as I  st$  u$ 
where t and u are the total standard deviation L for the K2HPO4 syringe-phantom and the 
water syringe-phantom respectively. The concentration of K2HPO4 for which  v 2I or 
 v 2st$  u$ is defined as the discrete sensitivity of a given measurement method.  
An additional non-discrete sensitivity test was sought to compare the measurement 
methods within the range of K2HPO4 concentration equivalents expected to be measured using 
SEQCT or DEQCT. In the second test, the K2HPO4 concentration, HU, and aBMD 
measurements in air and scattering conditions from Sections 3.1.1.2 and 3.1.2.2 were 
combined with the average concentration, HU, and aBMD measurements in this experiment, 
plotted against the known K2HPO4 concentration, and fit with a new regression. Regressions 
with a y-intercept consistent with 0 within the 95% confidence intervals were re-plotted with the 
y-intercept set to 0. The smallest detectable change outside the 95% confidence interval in 
K2HPO4 concentration equivalent from those associated with the normal value of a post-
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menopausal woman (57,112) was determined for DECT and SECT in air and in scattering 
conditions and for DXA and this smallest detectable change was defined as the sensitivity. 
Concentrations of K2HPO4 determined to be indistinguishable from water with 95% confidence 
with a measurement method in the first sensitivity analysis were excluded from this analysis for 
that measurement method. 
3.3.2. Results 
3.3.2.1. DECT Sensitivity 
The measured concentration of K2HPO4 solution with DECT as a function of the 
concentration (from phantom preparation) used to estimate the sensitivity in the first test is 
plotted in Figure 42. The smallest detectable K2HPO4 concentration from this experiment was 
0.16% by volume in air and 2.5% in scattering conditions. The extended K2HPO4 concentration 
plot from the second sensitivity test is shown in Figure 43. The equation for the in-air 
regression with 95% confidence is  1.08 
 0.02& mg/mL . The normal vBMD of 
postmenopausal women as assessed with QCT is approximately 126 mg/mL K2HPO4 (112), 
which would according to the fit correspond to a measured concentration of 1.08126 
136 mg/mL. The lower 95% confidence limit on a measurement of 136 mg/mL is 1.06 !
126 mg/mL   134 mg/mL or
 
134/1.08  124 mg/mL true K2HPO4 concentration. The 
minimum difference in true K2HPO4 concentration from normal that can be detected with 95% 
confidence is therefore 126 mg/mL ' 124 mg/mL  2 mg/mL or 2 mg/mL ÷ 126 mg/mL= 2%. 
Likewise, the equation for the regression in scatter is   0.73 
 0.01& mg/mL, so a decrease 
in normal bone mineral in excess of 2 mg/mL true K2HPO4 concentration (2%) is necessary 
before detection. 
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Figure 42: Material density image concentration measured in air and in scattering conditions for 
a series of K2HPO4 syringe-phantoms for which the concentration of the solute decreases 
logarithmically. The error bars represent 2I for that measurement, where  is the difference 
between the measurement for that K2HPO4 concentration and water. The error bars are too 
small to be visible for most points in air. The smallest K2HPO4 concentration distinguishable 
from water in air was 0.16% and 2.5% in scatter. 
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Figure 43: Extended plot of K2HPO4 concentration for the purpose of evaluating DECT 
sensitivity. Error bars on the y-axis indicate total variation for each measurement. The dotted 
lines indicate the 95% confidence intervals. The equation of the regression in air with 95% 
confidence is   1.08 
 0.02& xc yz/y{. The equation of the regression in scattering 
conditions with 95% confidence is   0.73 
 0.01& xc yz/y{. 
3.3.2.2. SECT Sensitivity 
The measured concentration of K2HPO4 solution with SECT as a function of the 
concentration (from phantom preparation) used to estimate the sensitivity in the first test is 
plotted in Figure 44. The smallest detectable K2HPO4 concentration from this experiment was 
0.16% by volume in air and 2.5% in scattering conditions. The 120 and 80 kVp scatter 
regression from the extended K2HPO4 concentration plot in the second sensitivity test (Figure 
45) was found to have an offset consistent with zero, so the offset was set to 0 and the slope 
recalculated with this constraint (shown). The equation for the 120 kVp regression with 95% 
confidence is   1.54 
 0.04 HU mg/mL&  19 
 11  HU in air and   1.12 

0.02 HU mg/mL& in scattering conditions. The equation for the 80 kVp regression with 
95% confidence is   2.09 
 0.05 HU mg/mL&  21 
 14 HU in air and  
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1.48 
 0.03 HU mg/mL& in scattering conditions. According to the regression for a 120 
kVp HU measurement in air, the normal vBMD of 126 mg/mL K2HPO4 corresponds to a HU of 
1.54 HU mg/mL126 mg/mL  19 HU  213 HU. The lower 95% confidence limit on a 
measurement of 213 HU is 1.50 HU mg/mL ! 126 mg/mL  8 HU    197 HU or
 
197 HU '
19 HU/1.54HU mg/mL  116 mg/mL K2HPO4. The minimum difference in K2HPO4 
concentration from normal that can be detected with 95% confidence is therefore 126 mg/mL '
116 mg/mL  10 mg/mL or 10 mg/mL ÷ 126 mg/mL = 8%. Using similar calculations, it was 
determined that a change of 2 mg/mL (2%) could be detected at 120 kVp in scattering 
conditions, a change of 10 mg/mL (8%) at 80 kVp in air and in scattering conditions a change 
of 3 mg/mL (2%). 
 
Figure 44: SECT HU measured in air and in scattering conditions at 120 and 80 kVp for a 
series of K2HPO4 syringe-phantoms for which the concentration of the solute decreases 
logarithmically. The error bars represent 2I for that measurement, where  is the difference 
between the measurement for that K2HPO4 concentration and water. The error bars are too 
small to be visible for most points in air. The smallest K2HPO4 concentration distinguishable 
from water in air was 0.16% and 2.5% in scatter for both 120 and 80 kVp. 
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Figure 45: Extended plot of K2HPO4 concentration for the purpose of evaluating SECT 
sensitivity. Error bars on the y-axis indicate total variation for each measurement; some are too 
small to be visible. The dotted lines indicate the 95% confidence intervals. The equation for the 
120 kVp regression with 95% confidence is   1.54 
 0.04 CD yz/y{&  19 
 11  CD 
in air and   1.12 
 0.02 CD yz/y{& in scattering conditions. The equation for the 80 
kVp regression with 95% confidence is   2.09 
 0.05 CD yz/y{&  21 
 14 CD in air 
and   1.48 
 0.03 CD yz/y{& in scattering conditions. 
3.3.2.3. DXA Sensitivity 
The measured concentration of K2HPO4 solution with DXA as a function of the 
concentration (from phantom preparation) used to estimate the sensitivity in the first test is 
plotted in Figure 46. The smallest detectable K2HPO4 concentration from this experiment was 
0.63 % by volume. The extended K2HPO4 aBMD plot from the second sensitivity test is shown 
in Figure 47. The equation for the regression with 95% confidence is   2.23 
 0.03 !
10"g/cm$ mg/ml & ' 8 
 1 ! 10$  g/cm$. The normal aBMD of postmenopausal 
women as assessed with DXA is approximately 0.99 g/cm2 (57). According to the regression, 
this corresponds to a K2HPO4 concentration of &  0.99 g/cm$  0.08 g/cm$/2.23 ! 10" 
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 480 mg/mL. The lower 95% confidence interval of 480 mg/mL is 2.20 ! 10" ! 480 g/cm$ '
9 ! 10$ g/cm$    0.97 g/cm$  or 0.97  0.08g/cm$/2.23 ! 10"g/cm$ mg/ml 
470 mg/mL K2HPO4 concentration. The minimum difference in true K2HPO4 concentration from 
normal that can be detected with 95% confidence is therefore 480 mg/mL ' 470 mg/mL 
10 mg/mL or 10 mg/mL ÷ 480 mg/mL = 2%. 
 
Figure 46: DXA aBMD measured for a series of K2HPO4 syringe-phantoms for which the 
concentration of the solute decreases logarithmically. The error bars represent 2I for that 
measurement, where  is the difference between the measurement for that K2HPO4 
concentration and water. The smallest K2HPO4 concentration distinguishable from water was 
0.31%.  
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Figure 47: Extended plot of K2HPO4 concentration for the purpose of evaluating DXA 
sensitivity. Error bars on the y-axis indicate total variation for each measurement; most are too 
small to be visible. The dotted lines indicate the 95% confidence intervals. The equation for the 
regression with 95% confidence is   2.23 
 0.03 ! 10"z/|y$ yz/y} & ' 8 
 1 !
10'2  z/|y2. 
 
The smallest concentration of K2HPO4 distinguishable from water in this experiment by 
each measurement method is summarized in Table 23 along with the magnitude of the different 
sources of variation for the measurement method at that concentration. Both the 120 kVp and 
80 kVp SECT scans were found to detect the smallest concentration of K2HPO4, with DECT in 
air slightly less sensitive, but both DECT and SECT in scattering conditions were found to be 
roughly half as sensitive as DXA in distinguishing K2HPO4 from water in this experiment. 
The smallest detectable change in concentration of K2HPO4 from normal in this 
experiment by each measurement method is summarized in Table 24. DECT in air and scatter 
was found to be more sensitive than DXA, although only slightly more sensitive than SECT in 
scattering conditions at 80 and 120 kVp with the techniques used. DXA and SECT at 120 and 
80 kVp are equally sensitive in this experiment in terms of the magnitude of K2HPO4 
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concentration detectable, although for DXA measurements this represent a smaller percentage 
change from normal. 
 
Table 23: The minimum discrete amount of K2HPO4 by volume percentage and concentration 
that can be distinguished from water by each measurement method in air and in scattering 
conditions when applicable. The magnitude of each source of variation for that measurement 
method in the measurement of the listed concentration is also shown for comparison. 
Measurement 
Method 
% K2HPO4 
Solution 
K2HPO4 
Concentration 
(mg/mL) 
σp σi σr σn σt 
SECT 
(120 kVp Air) 0.16% 3.8 0.2 HU 
0.2 
HU 0.1 HU 2 HU 2 HU 
SECT 
(80 kVp Air) 0.16% 3.8 0.2 HU 
0.1 
HU 0.4 HU 2 HU 2 HU 
DECT 
(Air) 0.16% 7.6 
-0.09 
mg/mL 
-0.05 
mg/mL 
0.4 
mg/mL 
1.3 
mg/mL 
1.4 
mg/mL 
DXA 0.31% 7.6 0.004 g/cm2 - 
0.004 
g/cm2 - 
0.005 
g/cm2 
SECT 
(120 kVp 
Scatter) 
2.5% 61 2 HU 2 HU 1 HU 17 HU 17 HU 
SECT 
(80 kVp 
Scatter) 
2.5% 61 3 HU 2 HU 1 HU 26 HU 26 HU 
DECT 
(Scatter) 2.5% 61 2 HU 2 HU 2 HU 12 HU 13 HU 
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Table 24: The smallest detectable reduction in K2HPO4 concentration from normal at the 95% 
confidence interval of the regression as a concentration and percentage of the normal value. 
The normal K2HPO4 concentration equivalent vBMD for post-menopausal women is estimated 
at 126 mg/mL. 
Measurement Method K2HPO4 Concentration (mg/mL) Percentage 
DECT (Air) 2 2% 
DECT (Scatter) 2 2% 
SECT (120 kVp Scatter) 3 2% 
SECT (80 kVp Scatter) 3 2% 
DXA 10 3% 
SECT (120 kVp Air) 10 8% 
SECT (80 kVp Air) 10 8% 
3.3.3. Discussion 
 The two different experiments for each measurement method gave two different 
perspectives on its sensitivity. The experiment in which differentiation of K2HPO4 from water 
was the goal highlighted the significant effect of scatter on the variation of SECT and DECT, 
and it is clear from Table 23 that the increase in total variation L in these measurement 
methods in scattering conditions, driven by increases in noise, is responsible.  
A better understanding of the sensitivity expected in clinical measurements is given by 
the second experiment, in which the slope of the regression and the uncertainty of the 
regression parameters determines the modality’s sensitivity. DECT was able to detect a smaller 
change in normal bone K2HPO4 concentration in air and in scattering conditions relative to 
DXA, indicating greater sensitivity (Table 24). Previous research (112) has shown that normal 
and osteoporotic bone densities for post-menopausal women correspond to K2HPO4 
concentrations of approximately 126 ± 24 and 79 ± 24 mg/mL, respectively. The smallest 
detectable change of ~2-3 mg/mL with DECT in air and both DECT and SECT in scattering 
conditions is well within the standard deviation of the mean value for each population (24 
mg/mL). The smallest detectable change of ~10 mg/mL DXA and SECT in scatter found is 
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likewise sufficient for distinguishing osteoporotic patients from non-osteoporotic patients. Based 
on our results, in theory a DECT or SECT measurement could detect a change in BMD before 
DXA.  
The rankings of the measurement methods by sensitivity are different for the two 
experiments. The results from the second experiment indicating DECT measurements in air 
and both DECT and SECT measurements in scattering conditions are more sensitive than DXA 
(Table 24) are likely due to the fact that two different equivalent concentrations K2HPO4 are 
being used as the reference. The K2HPO4 concentration equivalent of trabecular BMD 
assessed by SEQCT is much less than the K2HPO4 concentration equivalent of the integrated 
trabecular and cortical BMD that is assessed by DXA. This result then highlights a theoretical 
advantage of DECT and SECT. The ability to measure BMD specifically for trabecular bone as 
possible with DECT may further increase its relevance and sensitivity over DXA for detecting a 
change in normal BMD for postmenopausal women. However, DECT sensitivity may be 
impacted by the changes in slope from uniform geometry seen in some concentric phantom 
concentration measurements (Section 3.2.1.2.1). 
 It is important to remember that both sensitivity and variation determine the usefulness 
of a measurement method in screening for small changes in BMD. Scatter is present in clinical 
measurement; therefore, despite the results indicated in Tables 23 and 24, the much reduced 
total variation of DXA compared to SECT measurements in scattering conditions (0.2% vs 1%) 
(Table 18) as well as the reduced dose and cost may more than compensate for the very slight 
reduction in sensitivity and make DXA the preferred modality. It is also important to note that 
there was no attempt to match the dose of the DECT and SECT techniques, so it is possible 
that the theoretical sensitivity of SECT could be even greater than that found in these results.  
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3.4. Subaim 4: Correlation of Base Pairs 
3.4.1. Materials and Methods 
In order to directly compare the performance of DECT concentration with DXA aBMD, a 
single basis pair for which to evaluate all phantoms is desirable. To assess the correlation 
between different DECT material decomposition basis pairs, the measurement of the 
concentration of the solute in the Optiray 320, K2HPO4, and 10 gm% K2HPO4 solution uniform 
syringe-phantoms was made using each of the following basis pairs: Optiray 320-water, 
K2HPO4-water and 10 gm% K2HPO4 solution-ethanol. Identical ROIs were drawn on the 
constituent basis pair images for each additional basis pair. The concentration of each solute in 
each basis pair image was plotted against the concentration of the solute measured with the 
constituent basis pair. The data were fit with a linear regression and their correlations 
evaluated. 
3.4.2. Results 
The correlation between the GSI-derived concentration of the constituent solute and the 
concentration of each other solute was perfectly correlated (R2=1) for each set of syringe-
phantoms except for the measured Optiray 320 concentration of the 10 gm% K2HPO4 solution 
syringe-phantoms, which was very highly correlated (R2 > 0.995). The results are summarized 
in Figures 49-51 and Table 25. It is interesting to note the very high concentrations of 10 gm% 
K2HPO4 solution measured using the of 10 gm% K2HPO4 solution-ethanol basis pair for each 
set of syringe-phantoms relative to the measured concentration of K2HPO4. This is because the 
concentration of two different solutes is being assessed (pure K2HPO4 vs. a solution of K2HPO4 
in water). 
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Figure 48: The solute concentrations with different material decomposition basis pairs are 
measured in the syringe-phantom set containing Optiray 320 and water and plotted against the 
derived Optiray 320 concentration using the Optiray 320-water basis pair.  
 
Figure 49: The solute concentrations with different material decomposition basis pairs are 
measured in the syringe-phantom set containing K2HPO4 and water and plotted against the 
derived K2HPO4 concentration using the K2HPO4 -water basis pair.  
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Figure 50: The solute concentrations with different material decomposition basis pairs are 
measured in the syringe-phantom set containing 10 gm% K2HPO4 solution and ethanol and 
plotted against the derived concentration of 10 gm% K2HPO4  solution using the 10 gm% 
K2HPO4 solution -ethanol basis pair.  
 
Table 25: The squared Pearson’s correlation coefficient for each linear regression of the 
derived concentration using a given basis pair against the constituent basis pair for that series 
of syringe-phantoms. 
Base Pair Correlation (R2) Optiray 320 (Derived) 
K2HPO4 
(Derived) 
10 gm% K2HPO4 Solution 
(Derived) 
Optiray 320 1.000 1.000 1.000 
K2HPO4 1.000 1.000 1.000 
10 gm% K2HPO4 Solution 0.996 1.000 1.000 
 
3.4.3. Discussion 
The nearly perfect agreement between all basis pairs is an expected result based on 
the known principles of material decomposition (113). The lack of perfect agreement for the 
Optiray 320 basis pair decomposition of the 10 gm% K2HPO4 solution syringe-phantoms was 
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very likely due to the low concentrations of Optiray 320 measured and the subsequent lack of 
significant figures. With more significant figures the regression would expected to be perfect as 
well. However, the perfect agreement found in this experiment may depend on the mass 
attenuation coefficient of the two materials in each basis pair being sufficiently different at the 
effective energies used in DECT. The ethanol-water basis pair is not expected to produce 
similar results due to difficulties in the material decomposition process, possibly related to the 
similar mass attenuation coefficients of the two basis material in the range of rsDECT x-ray 
energies (Section 3.1.1.3) . The advantage of perfect correlation between different basis pairs 
is the ability to translate density estimates between different materials, as investigated in the 
next section. 
4. Specific Aim II: Relating DECT to DXA 
4.1. Subaim 1: Correlation of DECT and DXA 
4.1.1. Materials and Methods 
 To directly compare the performance of DECT and DXA, it is useful to establish if there 
is a relationship between measurements made by the two methods. To investigate a possible 
predictable relationship between material density image concentration measurements acquired 
from DECT and aBMD acquired from DXA, K2HPO4 concentrations with the K2HPO4-water 
basis pair were measured in air for each of the Optiray 320, K2HPO4, and 10 gm% K2HPO4 
solution uniform syringe-phantoms and plotted with the corresponding DXA aBMD 
measurements on the ordinate. Here the perfectly linear relationship between each basis pair 
established in Section 3.4.2 was exploited to combine the measurements of each syringe-
phantom on to a single plot using the same basis pair (K2HPO4-water). The data were fit with a 
linear regression and the degree of correlation was assessed with the Pearson’s correlation 
coefficient.  
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4.1.2. Results 
The correlation between DXA aBMD and K2HPO4 concentration for the uniform two-
material syringe-phantoms is summarized in Figure 51. The two measurements were highly 
correlated (R2 > 0.992). 
 
Figure 51: Correlation of K2HPO4 concentration measured from material density images using 
the K2HPO4-water basis pair for three different solutes with aBMD measured with DXA. 
4.1.3. Discussion 
 Figure 51 is very interesting because it suggests that concentration measurements 
acquired with DECT in air are linearly correlated with DXA aBMD measurements, despite the 
two measurement methods assessing composition using two very different methodologies. Due 
to the perfectly linear relationship between different material density image basis pairs, a 
similar linear regression with the exact same Pearson’s correlation coefficient could be found 
for DXA aBMD and nearly any other material, provided there was sufficient difference between 
the mass attenuation coefficients of the two material bases in the appropriate energy range. 
While the relationship is geometrically dependent due to the DXA’s areal density 
 97 
 
measurements, a linear relationship between the two modalities suggests that it may indeed be 
possible to relate a DECT measurement to an aBMD measurement of a given sample. 
4.2. Subaim 2: DECT Integration and DXA Comparison 
4.2.1. Materials and Methods 
To evaluate the ability of material density image concentration measurement to predict 
DXA aBMD, 34 DECT, SECT, and DXA image sets were obtained, consisting of three uniform 
syringe-phantoms of each solute composition (Optiray 320, K2HPO4, 10 gm% K2HPO4 solution) 
plus one 2.5% K2HPO4 syringe-phantom, three phantoms from each set of concentric 
phantoms, including the shared (10% inner K2HPO4/10% outer Optiray 320) phantom, the QC 
phantom included with the Hologic Discovery DXA scanner (Figure 52), the European Spine 
Phantom (Figure 53), and nine animal bones as unknown, arbitrary anthropomorphic samples. 
The European Spine Phantom (114) (Quality Assurance and Radiology in Medicine, 
Möhrendorf, Germany) is a tool designed to relate CT and DXA measurements consisting of 
three lumbar spine inserts designed to provide a clinical range of three different bone mineral 
(HA) densities. The animal bones were of bovine or porcine origin obtained in a raw condition 
from a grocery store (neck bones) or in cured form from a pet clinic (all others). They included a 
shank, a collection of five neck bones, a femoral head, and a set of two vertebral bodies 
(Figure 54).  
The image sets were obtained from the DECT scanner using the GSI-6 DECT protocol 
(Table 11) with 5 mm images and at 80 kVp/200 mA with a 1s tube rotation time and medium 
body filter selected. 80 kVp was selected instead of 120 due to the increased sensitivity to 
material composition. 2.5 mm images for the femoral head and one positioning of the vertebral 
bodies were obtained at 80 kVp. 
The animal bones were also scanned in the DXA scanner between PMMA blocks as 
used for the liquid solution phantoms (Figure 55). The vertebral bodies were oriented in two 
  
different positions in the DECT and DXA scanners, in
measurements. Instead of manual ROIs, the DXA software automatically identified bone 
material and corresponding ROIs for which the aBMD was determined
animal bones, and ESP. Because the DXA aBM
relied on user delineation of the 
measurements were averaged.
Figure 52: Left: Anthropomorphic QC phantom included with the Hologic 
scanner. The cuboid phantom is designed to produce a measured aBMD of about 1
the scanner. Center: DECT K
Figure 53: Left: The European Spine Phantom
Right: SECT 80 kVp HU image.
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 order to present different areas for aBMD 
 for the QC phantom, 
D measurements of the QC phantom and ESP 
individual vertebral bodies, three scans were acquired and the 
 
Discovery
2HPO4 material density map. Right: SECT 80 kVp HU image
. Center: DECT K2HPO4 material density map. 
 
 
 DXA 
 g/cm2 on 
. 
 
  
Figure 54: Top to bottom: Shank, femoral
vertebral bodies placed perpendicular to scan axis, neck bones. Left to right: photograph, 
DECT K2HPO4 material density map, SECT 80 kVp HU image.
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 head, vertebral bodies placed parallel to scan axis, 
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Figure 55: Arrangement of materials for measurement of animal bones with the DXA scanner. 
 
A methodology for processing and analyzing DECT and SECT data to produce an areal 
BMD in g/cm2 was devised to fully evaluate the relationship between DXA aBMD and material 
density image concentration measurements, as well as SECT HU measurements for 
comparison. To assist the comparison, the European Spine Phantom was scanned using the 
GSI-6 protocol (Table 11). The DECT and SECT scans of the European Spine Phantom were 
used to convert the raw K2HPO4 density and 80 kVp HU of each of the phantom’s three 
vertebral bodies to the true HA density provided by the manufacturer using a linear 
transformation function estimated by fitting the data (Figure 56). 
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Figure 56: Linear regression used to convert material density image-derived K2HPO4 
concentration (left) and 80 kVp HU (right) to HA concentration using HA density provided by 
QRM. The equation of the line for DECT K2HPO4 measurements is y = 0.8445x - 3.536 (in 
(mg/mL)/(mg/mL)). The equation of the line for SECT 80 kVp HU measurements is y = 0.5125x 
(in (mg/mL)/HU) - 6.800 (in mg/mL). 
 
A diagram of the CT image integration process is illustrated in Figure 57. Axial image 
stacks of the DECT material density map with the K2HPO4-water basis pair and the SECT HU 
map transformed into HA density were re-binned, avoiding interpolation, into coronal-plane 
images using ImageJ image analysis software (115). A threshold for “bone material” in the 
stack was visually determined and voxels below the threshold in each image were set to 0 
mg/mL. The images in each stack were arithmetically summed into a single image, on which a 
new threshold was applied to segment the “bone” or a manual ROI corresponding to the DXA 
ROI was placed. A measurement of the integrated density ~, or the sum of the value of each 
selected pixel in mg/mL HA, and the total area ] of the selected pixels in mm2 was  calculated 
for each summed image after segmentation. The estimate of aBMD in HA density, expressed in 
g/cm2 based on DECT and SECT data was then calculated as follows: 
Z+*  k  Q~ ! 111i  T / Q] ! 1k kk T , Equation 4.2.1-1 
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where ~ is the integrated density in units of mg/cm3 HA,  is the voxel volume in mL3, and ] is 
the total area of the selected pixels on the integrated DECT or SECT image.  
 
Figure 57: Simplified schematic diagram of the DECT or SECT image integration process for 
the ESP. A) An axial image set is re-binned into coronal images. A threshold is applied and the 
remaining voxels are set to zero B) The thresholded images are then integrated into a single 
image. C) A new threshold is applied and D) the resulting area (within an ROI in this case) is 
recorded along with the integrated density from which to calculate the aBMD (right). 
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The integration processing described was applied to the 34 DECT image sets. The 80 
kVp SECT images were processed in the same manner for comparison with a similar HA 
conversion (Figure 56) applied, excluding three phantoms in which a large number of pixels 
attained the maximum CT number (25% Optiray 320 uniform syringe-phantom, 10%/30% 
concentric phantom, and shank). The HA aBMD (g/cm2) for DECT and SECT were plotted with 
DXA aBMD measurements on the ordinate and the data were fit with a linear regression. 
Correlation was assessed using Pearson’s correlation coefficient and a slope and offset 
calculated with 95% confidence. The DECT and SECT HA aBMD were compared with DXA 
aBMD with Bland-Altman analysis. 
4.2.2. Results 
4.2.2.1. DECT Integration 
 The measurements of aBMD between the two modalities were found to be correlated 
(R2 = 0.983, p < 0.0001), and the regression (Figure 58) is y = (0.95 ± 0.04)x (in (g/cm2)/ 
(g/cm2)) + (0.28 ± 0.09) (in g/cm2). The range of DXA aBMD values expected to be seen in 
clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2,(53) is shown in more detail in 
Figure 59. The Bland-Altman analysis, (Figure 60, Table 26) yielded a mean difference of 0.205 
g/cm2 with a standard error of 0.005 g/cm2, indicating a consistent underestimation of DXA 
aBMD by DECT aBMD. The 95% confidence interval for the limits of agreement between DXA 
and material density image-derived aBMD were calculated to be -0.16—0.57 g/cm2. In the 
clinical range, Bland-Altman analysis yielded a mean difference of 0.27 g/cm2 with a standard 
error of 0.01 g/cm2, and a 95% confidence interval for the limits of agreement of -0.05—0.60 
g/cm2. 
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Figure 58: Correlation of integrated HA aBMD acquired from DECT images and DXA aBMD. 
The linear regression is plotted with 95% confidence intervals (dotted lines) and the line of 
equivalence. The equation of the regression is y = (0.95 ± 0.04)x (in (g/cm2)/(g/cm2)) + (0.28 ± 
0.09) (in g/cm2). 
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Figure 59: Enlargement of Figure 58 showing the range of DXA aBMD values expected to be 
seen in clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2. Dotted lines 
represent the 95% confidence intervals and the line of equivalence is shown for reference. 
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Figure 60: Bland-Altman analysis comparing DECT aBMD and DXA aBMD of a variety of 
phantoms illustrated in Figure 58. The mean difference was 0.205 g/cm2 with a standard error 
of 0.005 g/cm2. 
 
Table 26: Bland-Altman statistics of comparison between DECT HA aBMD and DXA aBMD. 
Bias 
(g/cm2) 
Standard Deviation of 
Bias (g/cm2) 
Upper Limit of 
Agreement (95%) 
Lower Limit of 
Agreement (95%) 
0.21 0.18 0.57 -0.16 
 
4.2.2.2. SECT Integration 
The correlation for SECT integration measurements is nearly as high (R2 = 0.968) as for DECT 
(Figures 62-63). The regression was found to have a y-intercept consistent with 0 within the 
95% confidence intervals (0.05 ± 0.1) and so was re-plotted with the y-intercept set to 0. The 
regression, with 95% confidence intervals, is y = (1.25 ± 0.5)x (in (g/cm2)/ (g/cm2)). The Bland-
Altman analysis (Figure 63, Table 27) yielded a mean difference of -0.276 g/cm2 with a 
standard error of 0.008 g/cm2, indicating a consistent underestimation of DXA aBMD by SECT 
aBMD. The 95% confidence interval for the limits of agreement between DXA and SECT-
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derived aBMD were calculated to be -0.17—0.72 g/cm2. In the clinical range, Bland-Altman 
analysis yielded a mean difference of 0.24 g/cm2 with a standard error of 0.01 g/cm2, and a 
95% confidence interval for the limits of agreement of -0.10—0.58 g/cm2. 
 
Figure 61: Correlation of integrated 80 kVp HU areal density acquired from SECT images and 
DXA aBMD. The linear regression is plotted with 95% confidence intervals, represented as 
dotted lines. The equation of the regression is y = (1.25 ± 0.5)x (in (g/cm2)/(g/cm2)). The line of 
equivalence is shown for comparison. 
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Figure 62: Enlargement of  Figure 61 showing the range of DXA aBMD values expected to be 
seen in clinical measurements of the lumbar spine, about 0.65-1.5 g/cm2. Dotted lines 
represent the 95% confidence intervals of the regression. The line of equivalence is shown for 
comparison. 
 
Figure 63: Bland-Altman analysis comparing SECT aBMD and DXA aBMD of a variety of 
phantoms illustrated in Figure 61. The mean difference was -0.276 g/cm2 with a standard error 
of 0.008 g/cm2. 
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Table 27: Bland-Altman statistics of comparison between SECT HA aBMD and DXA aBMD. 
Bias 
(g/cm2) 
Standard Deviation of 
Bias (g/cm2) 
Upper Limit of 
Agreement (95%) 
Lower Limit of 
Agreement (95%) 
0.21 0.21 0.14 -0.70 
 
4.2.3. Discussion  
 We have taken a three-dimensional imaging modality and created a two-dimensional 
image for the purpose of comparing its performance to a two-dimensional modality. aBMD 
measurements in g/cm2 from DECT integration are well-correlated with aBMD in g/cm2 
measured with DXA. The slope (near unity, 0.95 ± 0.04) of the linear regression to the DECT 
HA areal density plot lends credibility to the DECT integration methodology and suggests the 
two measurement methods are indeed assessing the same fundamental quantity, the total 
volumetric density of bone mineral. However, the 95% upper and lower limits of agreement of 
the DXA aBMD (-0.16-0.57 g/cm2) are of the same magnitude as a change in DXA aBMD from 
normal to osteoporotic (about 0.3 g/cm2) (53), limiting the utility of a conversion between the 
two measurements.  
SECT integration measurements are also very well-correlated (R2 = 0.968) with DXA 
aBMD. However, the trend of SECT integration measurements is an increasing distance from 
the line of equivalence with increasing SECT aBMD (Figure 62). The limits of agreement for 
SECT aBMD measurements with DXA aBMD measurements are not an improvement over 
those for DECT (Table 27). 
The aBMDs from DECT and SECT in this experiment were both calculated from images 
acquired in air. Based on results obtained in Sections 3.1. and 3.2, the effect of surrounding 
tissue may further complicate the observed linear relationship of each with DXA aBMD in 
clinical imaging. There is some uncertainty introduced in the manual identification of bone 
material and the re-binning process used. Additionally, the reconstruction does not exactly 
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match the fan-beam reconstruction used in DXA imaging. Finally, the difference in the 
calculation and application of the pixel-by-pixel HA density in the dual-energy processing of 
DECT and DXA (DECT used a correction based on known HA densities, while DXA used an 
empirical correction based on the “soft tissue” composition) may have affected our results. All 
of these factors should be considered in any future applications of this method. 
5. Conclusion 
We have shown that the rsDECT measurements of material concentration obtained with 
material density images have an RMS accuracy error greater than 5% in air. Accuracy is further 
reduced under scattering (clinical) conditions (~8-27%), and to a lesser extent with different 
GSI protocols and patient positioning (< 5%). The accuracy of material density image 
concentration measurements is also impacted by the attenuation geometry of bone, where a 
lower-attenuating material of interest is surrounded by a more highly attenuating material. The 
denser the higher-attenuating material, the higher the measured concentration of the inner 
material tends to be. These effects, (excepting the effects of DECT protocol), are all observed 
in SECT data well, suggesting that the dual-energy reconstruction algorithm is not fully 
compensating for effects inherent in the single-energy data used in the reconstruction.  It is 
important to emphasize that the processing of the dual-energy images in the material density 
images is only theoretically understood; the details of the implementation, including the 
reconstructions of the integrated signals (e.g. if it is a linear or higher order function 
(9,113,116)) and ways in which single-energy inaccuracies could perpetuate to dual-energy 
data, is unknown.  
Based on our assessment of sensitivity, DECT measurements in scattering conditions are 
marginally more sensitive than DXA to a change in BMD from normal for postmenopausal 
women (~1 mg/mL K2HPO4) based on the 95% confidence limits of a regression fitted to 
K2HPO4 syringe-phantom measurements. While this is a promising result, the advantage of the 
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minor increase in sensitivity is undercut by the inaccuracies in the absolute concentration 
measurements as well as higher dose (in this study, the CTDIvol of DECT with GSI-6 protocol 
was 33.43 mGy, compared with 12.46 mGy and 5.59 mGy at 120 and 80 kVp, respectively, and 
0.020 mGy max for the DXA exam). Because Bland-Altman analysis demonstrates that DECT 
aBMD integration is not sufficiently accurate to reliably produce a DXA aBMD (measurements 
are expected to differ from DXA aBMD by anywhere from -0.16-0.57 g/cm2 compared  to a 
change in aBMD of about 0.3 g/cm2 expected between normal and osteoporotic bone) and is 
also comparable to SECT aBMD integration (-0.72-0.17 g/cm2), the overall advantage of DECT 
over SECT for assessing BMD based on this study is not clear. DECT material density images 
would require detailed corrections to produce concentration measurements with clinically 
acceptable accuracy. 
6. Future Work 
Our study was limited to comparing a single DECT vendor and implementation to a single 
DXA device. Although we were able to partially evaluate the rsDECT technique in the HD750 
scanner, the performance of an alternative commercial DECT implementation such as dual-
source DECT in characterizing BMD is unknown. While in our study the Hologic Discovery is 
assumed to have comparable performance to other currently used DXA scanners, the rsDECT 
has not yet been compared to any other device. 
Only a few material basis pairs were assessed for accuracy, at least one of which, ethanol-
water, being inappropriate for general use. There could be many other material basis pairs as 
problematic as ethanol-water. A wider range of materials evaluated with GSI dual-energy 
imaging could provide a more comprehensive picture of the technology, particularly clinically 
relevant materials such as iron (Fe). 
While the effect of a few different imaging parameters on material density image 
concentration measurements were assessed, there are many known sources of variation in 
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QCT that can be expected affect quantitative measurements (6,72,85). For example, there are 
many more GSI protocols, with many different associated imaging parameters, which have 
unknown effects on material density measurements. A detailed investigation of the effects of 
these parameters would greatly clarify the possible utility of DECT concentration 
measurements. 
A more sophisticated calibration of our K2HPO4 concentration measurements to HA density 
may have allowed for a better comparison to DXA aBMD. This could have been accomplished 
with a greater number solid phantoms consisting of varying concentrations of HA in water-
equivalent plastic. A programmed basis pair of HA-water may also have been evaluated. These 
calibration methods can be explored in future studies. 
Finally, additional insight may be gained by performing material density image 
measurements in real human vertebral bones, either from cadavers or in patient studies. 
Vertebral specimens from cadavers with intact marrow fat would be especially good for this 
investigation, so that the effect of real fat and bone on DECT concentration measurements 
could be assessed. Alternatively, patient images with both rsDECT and DXA could be obtained 
either in a prospective or retrospective study. Such a study would include patients of different 
genders, ethnicities, and age groups to benchmark DECT values against those from DXA, 
ideally comparing the change in BMD measured between the two modalities over time. In 
addition, the clinical value of separate cortical and trabecular measurements of BMD with 
rsDECT could be investigated.   
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